GNL Gut and Liver
  1. Lucas W. Thornblade, Paul Wong, Daneng Li, Susanne G. Warner, Sue Chang, Mustafa Raoof, Jonathan Kessler, Arya Amini, James Lin, Vincent Chung, Gagandeep Singh, Yuman Fong, Laleh G. Melstrom. Patterns of Whole Exome Sequencing in Resected Cholangiocarcinoma. Cancers 2021;13:4062
    https://doi.org/10.3390/cancers13164062
  2. Eleni Gkika, Maria A. Hawkins, Anca-Ligia Grosu, Thomas B. Brunner. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer. Front. Oncol. 2020;10
    https://doi.org/10.3389/fonc.2020.604387
  3. Aikaterini Mastoraki, Dimitrios Schizas, Nikolaos Charalampakis, Leon Naar, Maria Ioannidi, Diamantis Tsilimigras, Maria Sotiropoulou, Dimitrios Moris, Pantelis Vassiliu, Evangelos Felekouras. Contribution of Histone Deacetylases in Prognosis and Therapeutic Management of Cholangiocarcinoma. Mol Diagn Ther 2020;24:175
    https://doi.org/10.1007/s40291-020-00454-x
  4. Philipp Houben, Simon Schimmack, Christian Unterrainer, Bernd Döhler, Arianeb Mehrabi, Caner Süsal. Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report. Front. Surg. 2021;8
    https://doi.org/10.3389/fsurg.2021.678392
  5. Hui Li, Rongqiang Liu, Haizhou Qiu, Yang Huang, Wenbin Liu, Jiaxin Li, Hong Wu, Genshu Wang, Dewei Li. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.829407
  6. Andreas W. Berger, Lukas Perkhofer, Thomas J. Ettrich. Aktuelle systemische Therapie beim cholangiozellulären Karzinom. Onkologie 2023;29:784
    https://doi.org/10.1007/s00761-023-01373-2
  7. Meng-yu Zhang, Ming Luo, Kai He, Xian-ming Xia, Jie-ping Wang. NTCP Change in Rats of Hilar Cholangiocarcinoma and Therapeutic Significance. Technol Cancer Res Treat 2022;21:153303382211096
    https://doi.org/10.1177/15330338221109646
  8. Chunying Xie, Zhenxing Huang, Zhaohui Huang, Xue Zhang, Siyuan Lou. microRNA-206 Suppresses Cholangiocarcinoma Cell Growth and Invasion by Targeting Jumonji AT-Rich Interactive Domain 2. Dig Dis Sci 2022;67:2994
    https://doi.org/10.1007/s10620-021-07121-z
  9. Zhi-Peng Liu, Wei-Yue Chen, Yan-Qi Zhang, Yan Jiang, Jie Bai, Yu Pan, Shi-Yun Zhong, Yun-Ping Zhong, Zhi-Yu Chen, Hai-Su Dai. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma. WJG 2022;28:948
    https://doi.org/10.3748/wjg.v28.i9.948
  10. Xinhua Song, Xianqiong Liu, Haichuan Wang, Jingxiao Wang, Yu Qiao, Antonio Cigliano, Kirsten Utpatel, Silvia Ribback, Maria G. Pilo, Marina Serra, John D. Gordan, Li Che, Shanshan Zhang, Antonio Cossu, Alberto Porcu, Rosa M. Pascale, Frank Dombrowski, Hongbo Hu, Diego F. Calvisi, Matthias Evert, Xin Chen. Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma. 2019;25:403
    https://doi.org/10.1158/1078-0432.CCR-18-0284
  11. Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. WJGS 2020;12:468
    https://doi.org/10.4240/wjgs.v12.i12.468
  12. Irvin Rexha, Fabian Laage-Gaupp, Julius Chapiro, Milena Anna Miszczuk, Johanna Maria Mijntje van Breugel, MingDe Lin, Menelaos Konstantinidis, Rafael Duran, Bernhard Gebauer, Christos Georgiades, Kelvin Hong, Nariman Nezami. Role of 3D quantitative tumor analysis for predicting overall survival after conventional chemoembolization of intrahepatic cholangiocarcinoma. Sci Rep 2021;11
    https://doi.org/10.1038/s41598-021-88426-x
  13. Vasile Sandru, Bogdan Silviu Ungureanu, Madalina Stan-Ilie, Ruxandra Oprita, Gheorghe G. Balan, Oana-Mihaela Plotogea, Ecaterina Rinja, Andreea Butuc, Afrodita Panaitescu, Alexandru Constantinescu, Dan Ionut Gheonea, Gabriel Constantinescu. Efficacy of Endobiliary Radiofrequency Ablation in Preserving Survival, Performance Status and Chemotherapy Eligibility of Patients with Unresectable Distal Cholangiocarcinoma: A Case-Control Study. Diagnostics 2022;12:1804
    https://doi.org/10.3390/diagnostics12081804
  14. Si Min Chiow, Hau Wei Khoo, Jee Keem Low, Cher Heng Tan, Hsien Min Low. Imaging mimickers of cholangiocarcinoma: a pictorial review. Abdom Radiol 2022;47:981
    https://doi.org/10.1007/s00261-021-03399-9
  15. Shubhadip Chakrabarti, Ummity Srinivasa Rao. Lightweight neural network for smart diagnosis of cholangiocarcinoma using histopathological images. Sci Rep 2023;13
    https://doi.org/10.1038/s41598-023-46152-6
  16. Jiena Wang, Weiwei Zhu, Junxue Tu, Yihui Zheng. Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation. J. Microbiol. Biotechnol. 2022;32:1262
    https://doi.org/10.4014/jmb.2207.07037
  17. Alessandra Gentilini, Giulia Lori, Alessandra Caligiuri, Chiara Raggi, Giovanni Di Maira, Mirella Pastore, Benedetta Piombanti, Tiziano Lottini, Annarosa Arcangeli, Stefania Madiai, Nadia Navari, Jesus M. Banales, Sabina Di Matteo, Domenico Alvaro, Lea Duwe, Jesper B. Andersen, Alessandro Tubita, Ignazia Tusa, Luca Di Tommaso, Claudia Campani, Elisabetta Rovida, Fabio Marra. Extracellular Signal‐Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells. Hepatology 2021;74:2007
    https://doi.org/10.1002/hep.31888
  18. Jiaqi Chen, Qiaoya Pan, Yang Bai, Xuepeng Chen, Yi Zhou. Hydroxychloroquine Induces Apoptosis in Cholangiocarcinoma via Reactive Oxygen Species Accumulation Induced by Autophagy Inhibition. Front. Mol. Biosci. 2021;8
    https://doi.org/10.3389/fmolb.2021.720370
  19. Samantha Sarcognato, Iris E. M. de Jong, Luca Fabris, Massimiliano Cadamuro, Maria Guido. Necroptosis in Cholangiocarcinoma. Cells 2020;9:982
    https://doi.org/10.3390/cells9040982
  20. Margaret M. Kozak, Diego A.S. Toesca, Rie von Eyben, Erqi L. Pollom, Daniel T. Chang. Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation. Advances in Radiation Oncology 2020;5:77
    https://doi.org/10.1016/j.adro.2019.08.003
  21. Yunxia Liu, Xia Liu, Yanhua Zhou, Tingting Liu, Jie Li. Overexpression of miR-27a predicts poor prognosis and promotes the progression in cholangiocarcinoma. Clin Exp Med 2021;21:121
    https://doi.org/10.1007/s10238-020-00655-y
  22. Tao Wan, Hongguang Wang, Miaomiao Gou, Haiyan Si, Zhikuan Wang, Huan Yan, Tiee Liu, Shiyun Chen, Runjia Fan, Niansong Qian, Guanghai Dai. LncRNA HEIH promotes cell proliferation, migration and invasion in cholangiocarcinoma by modulating miR-98-5p/HECTD4. Biomedicine & Pharmacotherapy 2020;125:109916
    https://doi.org/10.1016/j.biopha.2020.109916
  23. Meng-yu Zhang, Ming Luo, Jie-ping Wang. FXR expression in rats of hilar cholangiocarcinoma. Sci Rep 2022;12
    https://doi.org/10.1038/s41598-022-12850-w
  24. Felix Dondorf, Frank Uteß, René Fahrner, Philipp Felgendreff, Michael Ardelt, Hans-Michael Tautenhahn, Utz Settmacher, Falk Rauchfuß. Liver Transplant for Perihilar Cholangiocarcinoma (Klatskin Tumor): The Essential Role of Patient Selection. Exp Clin Transplant 2019;17:363
    https://doi.org/10.6002/ect.2018.0024
  25. Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp, Stefan G. Hübscher. Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 2021;161:1764
    https://doi.org/10.1053/j.gastro.2021.07.046
  26. Roberta Marciano, Alberto Servetto, Cataldo Bianco, Roberto Bianco. Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report. J Med Case Reports 2017;11
    https://doi.org/10.1186/s13256-017-1443-8
  27. G. V. Zhuntova, T. V. Azizova, M. V. Bannikova, G. V. Sychugov. Characteristics of malignant neoplasms of the hepatobiliary system in the cohort of occupationally-exposed workers. jour 2022;21:4
    https://doi.org/10.52420/2071-5943-2022-21-1-4-12
  28. Gennaro Clemente, Andrea Tringali, Agostino M. De Rose, Elena Panettieri, Marino Murazio, Gennaro Nuzzo, Felice Giuliante. Mirizzi Syndrome: Diagnosis and Management of a Challenging Biliary Disease. Canadian Journal of Gastroenterology and Hepatology 2018;2018:1
    https://doi.org/10.1155/2018/6962090
  29. O. Melekhina, M. Efanov, R. Alikhanov, V. Tsvirkun, Y. Kulezneva, I. Kazakov, A. Vankovich, A. Koroleva, I. Khatkov. Percutaneous radiofrequency-assisted liver partition versus portal vein embolization before hepatectomy for perihilar cholangiocarcinoma. 2020;4:101
    https://doi.org/10.1002/bjs5.50225
  30. Weier Wang, Yanhong Fei, Jie Liu, Tunan Yu, Jianming Tang, Fangqiang Wei. Laparoscopic surgery and robotic surgery for hilar cholangiocarcinoma: an updated systematic review. ANZ Journal of Surgery 2021;91:42
    https://doi.org/10.1111/ans.15948
  31. Xinglei Qin, Min Lu, Gang Li, Yajun Zhou, Zhaoyang Liu. Downregulation of tumor‐derived exosomal miR-34c induces cancer‐associated fibroblast activation to promote cholangiocarcinoma progress. Cancer Cell Int 2021;21
    https://doi.org/10.1186/s12935-020-01726-6
  32. Qiang Wang, Yang An, Fengling Wang, Guosen Zhang, Lu Zhang, Huan Dong, Junfang Xin, Yongqiang Li, Shaoping Ji, Xiangqian Guo. OSchol: an online consensus survival web server for cholangiocarcinoma prognosis analysis. HPB 2021;23:545
    https://doi.org/10.1016/j.hpb.2020.08.011
  33. Lin-Qi Guo, Hua-Wei Sun, Chun-Ye Zhang, Yao Feng, Xin-Li Teng, Yi-Kun Qu. Efficacy of fluoxetine for anorexia nervosa caused by chemotherapy in patients with cholangiocarcinoma. 2019;98:e15945
    https://doi.org/10.1097/MD.0000000000015945
  34. David C. Wang, Hyun-Jung Jang, Tae Kyoung Kim. Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?. American Journal of Roentgenology 2020;214:1295
    https://doi.org/10.2214/AJR.19.21498
  35. Meimei He, Chen Cheng, Junxue Tu, Sha-Sha Ji, Dan Lou, Binglong Bai. Agrin expression is correlated with tumor development and poor prognosis in cholangiocarcinoma. J Int Med Res 2021;49:030006052110097
    https://doi.org/10.1177/03000605211009722
  36. Zhe Shi, Liyuan Zhou, Yan Zhou, Xiaoyan Jia, Xiangjun Yu, Xiaohong An, Yanzhen Han. Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway. BMB Rep 2022;55:299
    https://doi.org/10.5483/BMBRep.2022.55.6.044
  37. Wang Jianxiong, Wu Yu, Wang Juyi, Wang Guangxia. Intravenous combined with intrabiliary contrast‐enhanced ultrasound in the evaluation of resectability of hilar cholangiocarcinomas. J of Clinical Ultrasound 2022;50:931
    https://doi.org/10.1002/jcu.23268
  38. Meng Gao, Chengjie Mei, Yonghua Guo, Peng Xia, Hao Zhang, Yinyi Liu, Ye Yao, Xiang Jiang, Yufeng Yuan, Yawei Qian. Loss of FBP1 by aPKC-ι/Snail Pathway-Mediated Repression Promotes Invasion and Aerobic Glycolysis of Intrahepatic Cholangiocarcinoma. Front. Oncol. 2021;11
    https://doi.org/10.3389/fonc.2021.756419
  39. Carlos Constantin Otto, Anna Mantas, Lara Rosaline Heij, Daniel Heise, Maxime Dewulf, Sven Arke Lang, Tom Florian Ulmer, Edgar Dahl, Philipp Bruners, Ulf Peter Neumann, Jan Bednarsch. Preoperative predictors for non-resectability in perihilar cholangiocarcinoma. World J Surg Onc 2024;22
    https://doi.org/10.1186/s12957-024-03329-1
  40. Tao Wu, Ming-Sheng Lei, Xu-Zhao Gao, Ting-Gang Xiong, Kang Yang, Qian Gong, Rui Tang, Yue-Peng Tian, Xiao-Hua Fu. lncRNA SNHG16 Mediates Cell Proliferation and Apoptosis in Cholangiocarcinoma by Directly Targeting miR-146a-5p/GATA6 Axis. Biochem Genet 2021;59:1311
    https://doi.org/10.1007/s10528-021-10059-6
  41. Siriwoot Butsri, Veerapol Kukongviriyapan, Laddawan Senggunprai, Sarinya Kongpetch, Auemduan Prawan. All‑trans‑retinoic acid induces RARB‑dependent apoptosis via ROS induction and enhances cisplatin sensitivity by NRF2 downregulation in cholangiocarcinoma cells. Oncol Lett 2022;23
    https://doi.org/10.3892/ol.2022.13299
  42. Woo Jin Choi, Tommy Ivanics, Annabel Gravely, Steven Gallinger, Gonzalo Sapisochin, Grainne M. O’Kane. Optimizing Circulating Tumour DNA Use in the Perioperative Setting for Intrahepatic Cholangiocarcinoma: Diagnosis, Screening, Minimal Residual Disease Detection and Treatment Response Monitoring. Ann Surg Oncol 2023;30:3849
    https://doi.org/10.1245/s10434-023-13126-x
  43. Vincenzo Di Nunno, Giorgio Frega, Matteo Santoni, Lidia Gatto, Michelangelo Fiorentino, Rodolfo Montironi, Nicola Battelli, Giovanni Brandi, Francesco Massari. BAP1 In Solid Tumors. Future Oncol. 2019;15:2151
    https://doi.org/10.2217/fon-2018-0915
  44. Tingting Shi, Asahiro Morishita, Hideki Kobara, Tsutomu Masaki. The Role of microRNAs in Cholangiocarcinoma. IJMS 2021;22:7627
    https://doi.org/10.3390/ijms22147627
  45. Hans-Michael Hau, Mareen Devantier, Nora Jahn, Elisabeth Sucher, Sebastian Rademacher, Daniel Seehofer, Robert Sucher. Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA). Cancers 2021;13:4772
    https://doi.org/10.3390/cancers13194772
  46. Seogsong Jeong, Qingbao Cheng, Lifeng Huang, Jian Wang, Meng Sha, Ying Tong, Lei Xia, Longzhi Han, Zhifeng Xi, Jianjun Zhang, Xiaoni Kong, Jinyang Gu, Qiang Xia. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer 2017;17
    https://doi.org/10.1186/s12885-017-3464-5
  47. Keisuke Ishigami, Katsuhiko Nosho, ,Hideyuki Koide, Shinichi Kanno, Kei Mitsuhashi, Hisayoshi Igarashi, Masahiro Shitani, Masayo Motoya, Yasutoshi Kimura, Tadashi Hasegawa, Hiroyuki Kaneto, Ichiro Takemasa, Hiromu Suzuki, Hiroshi Nakase. MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer. 2018;39:1127
    https://doi.org/10.1093/carcin/bgy075
  48. Xifang Wang, Xiaomin Zhang, Jingying Sun, Yang Sun, Yuan Zhang, Li He, Ping Wang, Feng Li, Chao Sun. Guanine nucleotide exchange factor T exerts the cancer-promoting function in cholangiocarcinoma by enhancing the Wnt-GSK-3β-β-catenin cascade via regulation of Rac1/Cdc42. Toxicology and Applied Pharmacology 2023;467:116492
    https://doi.org/10.1016/j.taap.2023.116492
  49. Simone Brivio, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview. gene expr 2018;18:31
    https://doi.org/10.3727/105221617X15088670121925
  50. Gaya Spolverato, Giulia Capelli, Giulia Lorenzoni, Dario Gregori, Jin He, Irinel Popescu, Hugo P. Marques, Luca Aldrighetti, Shishir K. Maithel, Carlo Pulitano, Todd W. Bauer, Feng Shen, George A. Poultsides, Oliver Soubrane, Guillaume Martel, Bas Groot Koerkamp, Endo Itaru, Yi Lv, Timothy M. Pawlik. Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis. Ann Surg Oncol 2022;29:7634
    https://doi.org/10.1245/s10434-022-12156-1
  51. Paksiree Saranaruk, Sakda Waraasawapati, Yaovalux Chamgramol, Kanlayanee Sawanyawisuth, Natnicha Paungpan, Narumon Somphud, Chaisiri Wongkham, Seiji Okada, Sopit Wongkham, Kulthida Vaeteewoottacharn. Dense GM-CSFRα-expressing immune infiltration is allied with longer survival of intrahepatic cholangiocarcinoma patients. 2023;11:e14883
    https://doi.org/10.7717/peerj.14883
  52. Xin Huang, Yingmao Chen, Mingzhe Shao, Can Li, Aiqun Zhang, Jiahong Dong, Canhong Xiang. The value of 99mTc-labeled galactosyl human serum albumin single-photon emission computerized tomography/computed tomography on regional liver function assessment and posthepatectomy failure prediction in patients with hilar cholangiocarcinoma. 2020;41:1128
    https://doi.org/10.1097/MNM.0000000000001263
  53. Thomas B. Brunner, Oliver Blanck, Victor Lewitzki, Nasrin Abbasi-Senger, Felix Momm, Oliver Riesterer, Marciana Nona Duma, Stefan Wachter, Wolfgang Baus, Sabine Gerum, Matthias Guckenberger, Eleni Gkika. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. Radiotherapy and Oncology 2019;132:42
    https://doi.org/10.1016/j.radonc.2018.11.015
  54. Dimitra Ioanna Lampropoulou, Konstantinos Laschos, Gerasimos Aravantinos, Konstantinos Georgiou, Konstantinos Papiris, George Theodoropoulos, Maria Gazouli, Dimitrios Filippou. Association between homeobox protein transcript antisense intergenic ribonucleic acid genetic polymorphisms and cholangiocarcinoma. WJCC 2021;9:1785
    https://doi.org/10.12998/wjcc.v9.i8.1785
  55. Guanran Zhang, Xuyue Liu, Aiwen Jian, Kexin Zheng, Haiyan Wang, Jing Hao, Sujuan Zhi, Xiaoli Zhang, Gianfranco D. Alpini. CHST4 might promote the malignancy of cholangiocarcinoma. PLoS ONE 2022;17:e0265069
    https://doi.org/10.1371/journal.pone.0265069
  56. Paul Rogowski, Rieke von Bestenbostel, Franziska Walter, Katrin Straub, Lukas Nierer, Christopher Kurz, Guillaume Landry, Michael Reiner, Christoph Josef Auernhammer, Claus Belka, Maximilian Niyazi, Stefanie Corradini. Feasibility and Early Clinical Experience of Online Adaptive MR-Guided Radiotherapy of Liver Tumors. Cancers 2021;13:1523
    https://doi.org/10.3390/cancers13071523
  57. Samantha M. Ruff, Timothy M. Pawlik. Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies. Front. Oncol. 2024;14
    https://doi.org/10.3389/fonc.2024.1321683
  58. Mingzhen Bai, Wenkang Fu, Gang Su, Jie Cao, Long Gao, Chongfei Huang, Haidong Ma, Jinduo Zhang, Ping Yue, Bing Bai, Yanyan Lin, Wenbo Meng, Xun Li. The role of extracellular vesicles in cholangiocarcinoma. Cancer Cell Int 2020;20
    https://doi.org/10.1186/s12935-020-01526-y
  59. Alireza Rasekhi, Nasir Babakhan Kondori. Causes and Treatment of Bile Leaks at the Puncture Site After Percutaneous Transhepatic Biliary Decompression. AJIR 2019;3:8
    https://doi.org/10.25259/AJIR_3_2019
  60. Michela Anna Polidoro, Joanna Mikulak, Valentina Cazzetta, Ana Lleo, Domenico Mavilio, Guido Torzilli, Matteo Donadon. Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells. WJG 2020;26:4900
    https://doi.org/10.3748/wjg.v26.i33.4900
  61. Xusheng Zhang, Bendong Chen. Dermatomyositis with intrahepatic cholangiocarcinoma: a case report and data mining based on machine learning. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1206043
  62. Rongqi Sun, Tianli Chen, Meng Li, Zengli Liu, Bo Qiu, Zhipeng Li, Yunfei Xu, Chang Pan, Zongli Zhang. PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation. Biomedicine & Pharmacotherapy 2020;121:109583
    https://doi.org/10.1016/j.biopha.2019.109583
  63. Susan Acquisto, Renuka Iyer, Lauren Rosati, Natasha Pinheirn, Karen Driskill, Kaitlyn Musto, Heidi Lowitzer, Elizabeth Bradley, Lorraine Drapek. Cholangiocarcinoma: Treatment, Outcomes, and Nutrition Overview for Oncology Nurses. CJON 2018;22:E97
    https://doi.org/10.1188/18.CJON.E97-E102
  64. Xinqiang Wu, Xiaofeng Jiang, Zhaoyuan Liu, Ping Xue, Yubin Chen, Liangqi Cao, Zilong Wen, Yunqiang Tang. Effect of photodynamic therapy on peripheral immune system for unresectable cholangiocarcinoma. Photodiagnosis and Photodynamic Therapy 2024;49:104279
    https://doi.org/10.1016/j.pdpdt.2024.104279
  65. Tobias J. Weismüller. Role of Intraductal RFA: A Novel Tool in the Palliative Care of Perihilar Cholangiocarcinoma. Visc Med 2021;37:39
    https://doi.org/10.1159/000513970
  66. Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, Muhammad Atique, Usman Iqbal Aujla, Muhammad Azeemuddin, Zeba Aziz, Abu Bakar Hafeez Bhatti, Tariq Ali Bangash, Amna Subhan Butt, Osama Tariq Butt, Abdul Wahab Dogar, Javed Iqbal Farooqi, Faisal Hanif, Jahanzaib Haider, Siraj Haider, Syed Mujahid Hassan, Adnan Abdul Jabbar, Aman Nawaz Khan, Muhammad Shoaib Khan, Muhammad Yasir Khan, Amer Latif, Nasir Hassan Luck, Ahmad Karim Malik, Kamran Rashid, Sohail Rashid, Mohammad Salih, Abdullah Saeed, Amjad Salamat, Ghias-un-Nabi Tayyab, Aasim Yusuf, Haseeb Haider Zia, Ammara Naveed. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World J Gastroenterol 2024;30:1018
    https://doi.org/10.3748/wjg.v30.i9.1018
  67. Giulia Anichini, Laura Carrassa, Barbara Stecca, Fabio Marra, Chiara Raggi. The Role of the Hedgehog Pathway in Cholangiocarcinoma. Cancers 2021;13:4774
    https://doi.org/10.3390/cancers13194774
  68. Lauren J. McEneaney, Mathew Vithayathil, Shahid Khan. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2021.
    https://doi.org/10.1002/9781119756422.ch16
  69. Bi-Xia Liu, Chao-Tao Tang, Xi-Jian Dai, Ling Zeng, Fei Cheng, Youxiang Chen, Chunyan Zeng. Prognostic Value of S100P Expression in Patients With Digestive System Cancers: A Meta-Analysis. Front. Oncol. 2021;11
    https://doi.org/10.3389/fonc.2021.593728
  70. Brian M Fung, Keith D Lindor, James H Tabibian. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies. WJG 2019;25:659
    https://doi.org/10.3748/wjg.v25.i6.659
  71. Fabiana Crispo, Michele Pietrafesa, Valentina Condelli, Francesca Maddalena, Giuseppina Bruno, Annamaria Piscazzi, Alessandro Sgambato, Franca Esposito, Matteo Landriscina. IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives. Molecules 2020;25:3754
    https://doi.org/10.3390/molecules25163754
  72. Younghun Han, Jinyoung Byun, Catherine Zhu, Ryan Sun, Julia Y. Roh, Heather J. Cordell, Hyun-Sung Lee, Vikram R. Shaw, Sung Wook Kang, Javad Razjouyan, Matthew A. Cooley, Manal M. Hassan, Katherine A. Siminovitch, Trine Folseraas, David Ellinghaus, Annika Bergquist, Simon M. Rushbrook, Andre Franke, Tom H. Karlsen, Konstantinos N. Lazaridis, Christoph Schramm, David Shapiro, Elizabeth Goode, Katherine A. McGlynn, Lewis R. Roberts, Christopher I. Amos. Multitrait genome-wide analyses identify new susceptibility loci and candidate drugs to primary sclerosing cholangitis. Nat Commun 2023;14
    https://doi.org/10.1038/s41467-023-36678-8
  73. Prin Sungwan, Worachart Lert-itthiporn, Atit Silsirivanit, Nathakan Klinhom-on, Seiji Okada, Sopit Wongkham, Wunchana Seubwai. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. 2021;9:e11067
    https://doi.org/10.7717/peerj.11067
  74. Rongqi Sun, Zengli Liu, Bo Qiu, Tianli Chen, Zhipeng Li, Xiaoming Zhang, Yunfei Xu, Zongli Zhang. Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway. EBioMedicine 2019;47:142
    https://doi.org/10.1016/j.ebiom.2019.08.062
  75. Hans-Michael Hau, Felix Meyer, Nora Jahn, Sebastian Rademacher, Robert Sucher, Daniel Seehofer. Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma. JCM 2020;9:3152
    https://doi.org/10.3390/jcm9103152
  76. BilalO Al-Jiffry, Mohamed Al Saeed, Majed Al-Mourgi, AlaaE Younes, Samir Badr, Tamer Abdel-Rahman, Ayman Attalla, Abdullah Al-Sawat, Mohamed Hatem, Mahmoud El-Meteini, AliB Al-Jiffry. Outcome of combined complete excision of the caudate lobe with partial hepatectomy for treatment of resectable Klatskin tumors. Saudi Surg J 2019;7:63
    https://doi.org/10.4103/ssj.ssj_51_18
  77. Tanios S Bekaii-Saab, Juan W Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan, Mitesh J Borad, Ghassan K Abou-Alfa, Ping Jiang, Christine F Lihou, Huiling Zhen, Ekaterine Asatiani, Luis Féliz, Arndt Vogel. FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements . Future Oncol. 2020;16:2385
    https://doi.org/10.2217/fon-2020-0429
  78. Mohammad Golriz, Ali Ramouz, Ahmed Hammad, Ehsan Aminizadeh, Nastaran Sabetkish, Elias Khajeh, Omid Ghamarnejad, Carlos Carvalho, Hugo Rio-Tinto, De-Hua Chang, Ana Alagoa Joao, Gil Goncalves, Arianeb Mehrabi. Promising Results of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Perihilar Cholangiocarcinoma in a Systematic Review and Single-Arm Meta-Analysis. Cancers 2024;16:771
    https://doi.org/10.3390/cancers16040771
  79. Muhammad M. Munir, Laura Alaimo, Zorays Moazzam, Yutaka Endo, Henrique A. Lima, Chanza Shaikh, Aslam Ejaz, Joal Beane, Mary Dillhoff, Jordan Cloyd, Timothy M. Pawlik. Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. Journal of Surgical Oncology 2023;127:81
    https://doi.org/10.1002/jso.27102
  80. Priya Gopinathan, Nai-Jung Chiang, Chih-Hung Wang, Anirban Sinha, Yi-Cheng Tsai, Hsiu-Chi Tu, Shang-Cheng Hung, Pang-Hung Hsu, Yan-Shen Shan, Gwo-Bin Lee. Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients. Sensors and Actuators B: Chemical 2020;322:128569
    https://doi.org/10.1016/j.snb.2020.128569
  81. Fedir Vasilyevich Grynchuk, Ivan Ivanovich Dutka, Iryna Ihorivna Panchuk, Roman Anatolyevich Volkov, Michael Ivanovich Sheremet, Vitaliy Vasilyevich Maksymyuk, Volodymyr Volodymyrovich Tarabanchuk, Ihor Ivanovich Bilyk, Yuriy Mykolayovych Myshkovskii. Justification of Genetic Factors for Predicting the Risk of Acute Bleeding in Peptic Ulcer Disease. JMedLife 2020;13:255
    https://doi.org/10.25122/jml-2020-0041
  82. Dijie Zheng, Shiyu Chen, Kun Cai, Linhan Lei, Chunchen Wu, Chengyi Sun, Yazhu Deng, Chao Yu. Prodigiosin inhibits cholangiocarcinoma cell proliferation and induces apoptosis via suppressing SNAREs-dependent autophagy. Cancer Cell Int 2021;21
    https://doi.org/10.1186/s12935-021-02355-3
  83. Mumtaz Niazi, Pratik A. Shukla, Nikolaos Pyrsopoulos. Geriatric Gastroenterology. 2021.
    https://doi.org/10.1007/978-3-030-30192-7_51
  84. Hongyu Pei, Jing Yang, Wang Li, Xing Luo, Yi Xu, Xueying Sun, Qian Chen, Qi Zhao, Li Hou, Gang Tan, Daolin Ji. Solanum nigrum Linn.: Advances in anti-cancer activity and mechanism in digestive system tumors. Med Oncol 2023;40
    https://doi.org/10.1007/s12032-023-02167-7
  85. Jian‐min Sun, Hai‐tao Xu, Liang Zhao, Yu‐bao Zhang, Peng‐cheng Kang, Zeng‐fu Song, Hai‐shi Liu, Yun‐Fu Cui. Induction of cell‐cycle arrest and apoptosis in human cholangiocarcinoma cells by pristimerin. J of Cellular Biochemistry 2019;120:12002
    https://doi.org/10.1002/jcb.28485
  86. Junning You, Xiaolin Wang. Circ_HIPK3 Knockdown Inhibits Cell Proliferation, Migration and Invasion of Cholangiocarcinoma Partly via Mediating the miR-148a-3p/ULK1 Pathway. CMAR 2021;Volume 13:3827
    https://doi.org/10.2147/CMAR.S293823
  87. Quincy A. Hathaway, Dhairya A. Lakhani, Aneri B. Balar, Stell P. Santiago, Matthew R. Krafft, Mohamed Zitun, Carl R. Schmidt, Kelly T. Smith, Cathy Kim. Distal cholangiocarcinoma: case report and brief review of the literature. Radiology Case Reports 2023;18:423
    https://doi.org/10.1016/j.radcr.2022.10.072
  88. E. Roos, E.C. Soer, S. Klompmaker, L.L. Meijer, M.G. Besselink, E. Giovannetti, M. Heger, G. Kazemier, H.J. Klümpen, R.B. Takkenberg, H. Wilmink, T. Würdinger, F. Dijk, T.M. van Gulik, J. Verheij, M.J. van de Vijver. Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract. Critical Reviews in Oncology/Hematology 2019;140:8
    https://doi.org/10.1016/j.critrevonc.2019.05.011
  89. Evy Van Eecke, Helena Degroote, Aude Vanlander, Pieter Hindryckx. Outcome of primary ERCP versus primary PTC for biliary drainage in malignant hilar biliary strictures: a systematic review and meta-analysis. Surg Endosc 2022;36:7160
    https://doi.org/10.1007/s00464-022-09413-5
  90. Alphonse E. Sirica, Mario Strazzabosco, Massimiliano Cadamuro. Mechanisms and Therapy of Liver Cancer. 2022.
    https://doi.org/10.1016/bs.acr.2020.10.005
  91. Laurence Lacaze, Damien Bergeat, Chloé Rousseau, Laurent Sulpice, David Val-Laillet, Ronan Thibault, Karim Boudjema. High Visceral Fat is Associated with a Worse Survival after Liver Resection for Intrahepatic Cholangiocarcinoma. Nutrition and Cancer 2023;75:339
    https://doi.org/10.1080/01635581.2022.2117387
  92. Troels D. Christensen, Emil Maag, Ole Larsen, Claus L. Feltoft, Kaspar René Nielsen, Lars Henrik Jensen, Bonna Leerhøy, Carsten P. Hansen, Inna M. Chen, Dorte L. Nielsen, Julia S. Johansen. Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer. JHEP Reports 2023;5:100648
    https://doi.org/10.1016/j.jhepr.2022.100648
  93. Cheng Zhang, Jing-Yi Li, Fu-Zhou Tian, Gang Zhao, Hai Hu, Yue-Feng Ma, Yu-Long Yang. Long Noncoding RNA NEAT1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells. oncol res 2018;26:879
    https://doi.org/10.3727/096504017X15024935181289
  94. Olivia Grubman, Dyese Taylor, Madhavi Rayapudi, Lois Brustman. A case report of a pregnant woman diagnosed with intrahepatic cholangiocarcinoma (ICC) complicated by opioid tolerance. 2020;9
    https://doi.org/10.1515/crpm-2019-0062
  95. Qingliang Chen, Congmei Wang, Hongkai Zhang, Yun Li, Yunhong Cao, Yongxiang Zhang, Shaokun Liu, Zhen Li, Xiaoguo Xin, Xinwei Han. Expression levels of serum miRNA-195 in different types of patients with cholangiocarcinoma and its value to determine the prognosis thereof. Oncol Lett 2018
    https://doi.org/10.3892/ol.2018.8016
  96. Kun Jiang, Barbara A. Centeno. Primary Liver Cancers, Part 2. Cancer Control 2018;25:107327481774465
    https://doi.org/10.1177/1073274817744658
  97. Jessica R. Hale, Olusola O. Faluyi. Liver Cancers. 2018.
    https://doi.org/10.1007/978-3-319-92216-4_15
  98. Silvina Ilut, Vitalie Vacaras, Paula Rosu, Aurora Muntiu, Constantin Dina. Paraparesis and Disseminated Osteolytic Lesions Revealing Cholangiocarcinoma: A Case Report. JMedLife 2020;13:265
    https://doi.org/10.25122/jml-2020-0068
  99. 玉涛 刘. Current Status and Progress in the Treatment of Hilar Cholangiocarcinoma. ACM 2024;14:531
    https://doi.org/10.12677/ACM.2024.143735
  100. Jintian Tang, Ruibin Wang, Runjuan Tang, Peng Gu, Jing Han, Wukui Huang. CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production. Pathology - Research and Practice 2022;230:153732
    https://doi.org/10.1016/j.prp.2021.153732
  101. Yara Sarkis, Amine Al Soueidy, Hampig Raphael Kourie. Will advanced cholangiocarcinoma become a targetable malignancy?. Critical Reviews in Oncology/Hematology 2021;159:103233
    https://doi.org/10.1016/j.critrevonc.2021.103233
  102. Serena Mancarella, Grazia Serino, Francesco Dituri, Antonio Cigliano, Silvia Ribback, Jingxiao Wang, Xin Chen, Diego F. Calvisi, Gianluigi Giannelli. Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis. Cell Death Differ 2020;27:2330
    https://doi.org/10.1038/s41418-020-0505-4
  103. Xiufang Wu, Fei Qin, Qiangze Zhang, Jianling Qiao, Yulian Qi, Bing Liu. Immunotherapy improved cancer related pain management in patients with advanced Hepato-Pancreatic Biliary Cancers: A propensity score-matched (PSM) analysis. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.914591
  104. Chenli Si, Xiang Zhou, Jie Deng, Shijie Ye, Lingming Kong, Baofu Zhang, Weiming Wang. Role of ferroptosis in gastrointestinal tumors: From mechanisms to therapies. Cell Biology International 2022;46:997
    https://doi.org/10.1002/cbin.11804
  105. Osamah S Niaz, Max Seabrook, Talha Niaz, Irfan Ahmed, Rebecca Parrott, Ahsan Rao. Effects of different weight loss programmes on oncological outcomes following curative resection of digestive tract cancers. 2022;2022
    https://doi.org/10.1002/14651858.CD015146
  106. Alessandro Ottaiano, Mariachiara Santorsola, Anna Diana, Andrea Belli, Maria Luisa Lentini Graziano, Jessica Orefice, Renato Patrone, Annabella Di Mauro, Giosuè Scognamiglio, Fabiana Tatangelo, Mario De Bellis, Mauro Piccirillo, Francesco Fiore, Salvatore Stilo, Luca Tarotto, Marco Correra, Sara Di Lorenzo, Maurizio Capuozzo, Antonio Avallone, Lucrezia Silvestro, Antonella Bianco, Vincenza Granata, Piera Federico, Vincenzo Montesarchio, Bruno Daniele, Francesco Izzo, Guglielmo Nasti. Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real‐world study. Cancer Medicine 2024;13
    https://doi.org/10.1002/cam4.6892
  107. Zhaoqiang Yin, Jianlong Wang, Tao Li, Lifeng Ma, Jiansheng Kang, Guochao Liu. miR-188-5p and Host MALAT1 Regulate RBE Cell Migration, Invasion, and Apoptosis via Up-regulating PSMD10 in Cholangiocarcinoma. Appl Biochem Biotechnol 2023;195:655
    https://doi.org/10.1007/s12010-022-04136-8
  108. Hengyan Shen, Xinyu Bai, Jie Liu, Ping Liu, Tao Zhang. Screening potential biomarkers of cholangiocarcinoma based on gene chip meta-analysis and small-sample experimental research. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.1001400
  109. David M. de Jong, Sanne van de Vondervoort, Roy S. Dwarkasing, Michael Doukas, Rogier P. Voermans, Robert C. Verdonk, Wojciech G. Polak, Jeroen de Jonge, Bas Groot Koerkamp, Marco J. Bruno, Lydi M.J.W. van Driel. Endoscopic ultrasound in patients with resectable perihilar cholangiocarcinoma: impact on clinical decision-making. Endosc Int Open 2023;11:E162
    https://doi.org/10.1055/a-2005-3679
  110. Gilles S. van Tienderen, Bas Groot Koerkamp, Jan N. M. IJzermans, Luc J. W. van der Laan, Monique M. A. Verstegen. Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment. Cancers 2019;11:1706
    https://doi.org/10.3390/cancers11111706
  111. Yinghao Lv, Zhenzhen Wang, Kun Zhao, Guokun Zhang, Shuai Huang, Yongfu Zhao. Role of noncoding RNAs in cholangiocarcinoma (Review). Int J Oncol 2020
    https://doi.org/10.3892/ijo.2020.5047
  112. Hang Jiang, Wei Li, Zhiqian Xue, Wei Chen, Liping Zhao, Haihan Song, Jianhong Hou. lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p. Clinics and Research in Hepatology and Gastroenterology 2022;46:101915
    https://doi.org/10.1016/j.clinre.2022.101915
  113. Bijan Eghtesad, John J. Fung. Pouchitis and Ileal Pouch Disorders. 2022.
    https://doi.org/10.1016/B978-0-12-809402-0.00039-3
  114. Martin Coronel, Jeffrey H. Lee, Emmanuel Coronel. Endoscopic Ultrasound for the Diagnosis and Staging of Biliary Malignancy. Clinics in Liver Disease 2022;26:115
    https://doi.org/10.1016/j.cld.2021.08.010
  115. M. A. Nartailakov, R. R. Abdeev, I. Z. Salimgareev, A. R. Zagitov, R. R. Nuriakhmetov, I. I. Ivanov, K. N. Zolotukhin, I. V. Polyakov, L. I. Bashirova. An Analysis of the Liver Transplant Waiting List at the G. G. Kuvatov Republican Clinical Hospital. Kreativnaâ hirurgiâ i onkologiâ 2019;8:310
    https://doi.org/10.24060/2076-3093-2018-8-4-310-315
  116. Ahmad Abdullah Madkhali, Faisal Al-alem. Bile Duct Cancer. 2019.
    https://doi.org/10.5772/intechopen.84625
  117. Hao Shen, Jiawei Zhang, Yaodong Zhang, Qinchao Feng, Hongwei Wang, Gaochao Li, Wangjie Jiang, Xiangcheng Li. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Gene 2019;698:50
    https://doi.org/10.1016/j.gene.2019.02.044
  118. Kentaro Iwaki, Toshimi Kaido, Gen Yamamoto, Naoko Kamo, Shintaro Yagi, Kojiro Taura, Shinji Uemoto. Mass-forming intrahepatic cholangiocarcinoma with portal vein tumor thrombus and bile duct tumor thrombus: A case report. International Journal of Surgery Case Reports 2017;40:13
    https://doi.org/10.1016/j.ijscr.2017.08.059
  119. Tianhao Zhou, Debjyoti Kundu, Jonathan Robles-Linares, Vik Meadows, Keisaku Sato, Leonardo Baiocchi, Burcin Ekser, Shannon Glaser, Gianfranco Alpini, Heather Francis, Lindsey Kennedy. Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease. Cells 2021;10:2072
    https://doi.org/10.3390/cells10082072
  120. L. I. Moskvicheva. PHOTODYNAMIC THERAPY IN PATIENTS WITH HILAR CHOLANGIOCARCINOMA. Issled. prakt. med. (Print) 2019;6:75
    https://doi.org/10.17709/2409-2231-2019-6-1-7
  121. Zhijian Zhou, Jing Ma. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion. CBM 2019;24:173
    https://doi.org/10.3233/CBM-181980
  122. Patrick S. Plum, Timo Hess, Denis Bertrand, Isabelle Morgenstern, Oscar Velazquez Camacho, Christoph Jonas, Christina Alidousty, Britta Wagner, Stephanie Roessler, Thomas Albrecht, Jessica Becker, Vanessa Richartz, Barbara Holz, Sascha Hoppe, Huay Mei Poh, Burton Kuan Hui Chia, Cheryl Xueli Chan, Thushangi Pathiraja, Audrey SM Teo, Jens U. Marquardt, Alexis Khng, Michael Heise, Yao Fei, René Thieme, Sebastian Klein, Jing Han Hong, Simona O Dima, Irinel Popescu, Maria Hoppe‐Lotichius, Reinhard Buettner, Anja Lautem, Gerd Otto, Alexander Quaas, Niranjan Nagarajan, Steve Rozen, Bin Tean Teh, Benjamin Goeppert, Uta Drebber, Hauke Lang, Patrick Tan, Ines Gockel, Johannes Schumacher, Axel M. Hillmer. Integrative genomic analyses of European intrahepatic cholangiocarcinoma: Novel ROS1 fusion gene and PBX1 as prognostic marker. Clinical & Translational Med 2024;14
    https://doi.org/10.1002/ctm2.1723
  123. Gianluca Rompianesi, Marcello Di Martino, Alex Gordon-Weeks, Roberto Montalti, Roberto Troisi. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. WJGO 2021;13:332
    https://doi.org/10.4251/wjgo.v13.i5.332
  124. Charles W. Kimbrough, Jordan M. Cloyd, Timothy M. Pawlik. Surgical approaches for the treatment of perihilar cholangiocarcinoma. Expert Review of Anticancer Therapy 2018;18:673
    https://doi.org/10.1080/14737140.2018.1473039
  125. Na Su, Wubulitalifu Dawuti, Yan Hu, Hui Zhao. Noninvasive Cholangitis and Cholangiocarcinoma Screening Based on Serum Raman Spectroscopy and Support Vector Machine. SSRN Journal 2022
    https://doi.org/10.2139/ssrn.4166585
  126. Fatemeh Vatankhah, Neda Salimi, Amirreza Khalaji, Behzad Baradaran. Immune checkpoints and their promising prospect in cholangiocarcinoma treatment in combination with other therapeutic approaches. International Immunopharmacology 2023;114:109526
    https://doi.org/10.1016/j.intimp.2022.109526
  127. Francesca Saffioti, Vasileios K Mavroeidis. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. WJGO 2021;13:1336
    https://doi.org/10.4251/wjgo.v13.i10.1336
  128. Muhammad Musaab Munir, Yutaka Endo, Henrique A. Lima, Laura Alaimo, Zorays Moazzam, Chanza Shaikh, George A. Poultsides, Alfredo Guglielmi, Luca Aldrighetti, Matthew Weiss, Todd W. Bauer, Sorin Alexandrescu, Minoru Kitago, Shishir K. Maithel, Hugo P. Marques, Guillaume Martel, Carlo Pulitano, Feng Shen, François Cauchy, Bas Groot Koerkamp, Itaru Endo, Timothy M. Pawlik. Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional Analysis. J Gastrointest Surg 2023;27:544
    https://doi.org/10.1007/s11605-023-05578-z
  129. Med Dheker Touati, Anis Belhadj, Mohamed Raouf Ben Othmane, Fahd Khefacha, Syrine Khabthani, Ahmed Saidani. Mirizzi syndrome: A case report emphasizing safe management strategies and literature review. International Journal of Surgery Case Reports 2024;116:109297
    https://doi.org/10.1016/j.ijscr.2024.109297
  130. D. M. de Jong, K. Chehin, T. L.N. Meijering, M. Segbers, L. M.J.W. van Driel, M. J. Bruno, B. Groot Koerkamp, J. N.M. IJzermans, F. A. Verburg, Q. G. de Lussanet de la Sabloniere, R. S. Dwarkasing. Hybrid FDG-PET/MRI for Diagnosis and Clinical Management of Patients with Suspected Perihilar Cholangiocarcinoma: A Feasibility Pilot Study. Nucl Med Mol Imaging 2024
    https://doi.org/10.1007/s13139-024-00873-2
  131. Nikolaos Serifis, Diamantis I Tsilimigras, Daniel J Cloonan, Timothy M Pawlik. Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma. HMER 2021;Volume 13:93
    https://doi.org/10.2147/HMER.S278136
  132. Jun Wu, Shuang-Yong Cai, Xu-Liang Chen, Zhi-Tao Chen, Shao-Hua Shi. Mirizzi syndrome: Problems and strategies. Hepatobiliary & Pancreatic Diseases International 2024;23:234
    https://doi.org/10.1016/j.hbpd.2024.01.005
  133. Malinee Thanee, Sureerat Padthaisong, Manida Suksawat, Hasaya Dokduang, Jutarop Phetcharaburanin, Poramate Klanrit, Attapol Titapun, Nisana Namwat, Arporn Wangwiwatsin, Prakasit Sa-ngiamwibool, Narong Khuntikeo, Hideyuki Saya, Watcharin Loilome. Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. Cancer Metab 2021;9
    https://doi.org/10.1186/s40170-021-00249-6
  134. Priya Gopinathan, Nai‐Jung Chiang, Anandaraju Bandaru, Anirban Sinha, Wen‐Yen Huang, Shang‐Cheng Hung, Yan‐Shen Shan, Gwo‐Bin Lee. Exploring Circulating Tumor Cells in Cholangiocarcinoma Using a Novel Glycosaminoglycan Probe on a Microfluidic Platform. Adv Healthcare Materials 2020;9
    https://doi.org/10.1002/adhm.201901875
  135. Ghassan K. Abou-Alfa, Kristen Bibeau, Nikolaus Schultz, Amin Yaqubie, Brittanie Millang, Haobo Ren, Luis Féliz. Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic Cholangiocarcinoma. Targ Oncol 2022;17:517
    https://doi.org/10.1007/s11523-022-00906-w
  136. José Donizeti de MEIRA-JÚNIOR, Thiago Nogueira COSTA, Andre Luis MONTAGNINI, Sergio Carlos NAHAS, Jose JUKEMURA. ELEVATED CA 19-9 IN AN ASYMPTOMATIC PATIENT: WHAT DOES IT MEAN?. ABCD, arq. bras. cir. dig. 2022;35
    https://doi.org/10.1590/0102-672020220002e1687
  137. Orawan Waenphimai, Panupong Mahalapbutr, Kulthida Vaeteewoottacharn, Sopit Wongkham, Kanlayanee Sawanyawisuth. Multiple actions of NMS-P715, the monopolar spindle 1 (MPS1) mitotic checkpoint inhibitor in liver fluke-associated cholangiocarcinoma cells. European Journal of Pharmacology 2022;922:174899
    https://doi.org/10.1016/j.ejphar.2022.174899
  138. PHANI KUMAR SUNKARA, SREEDHARA CHAGANTY, K. RAMAKRISHNA. AN LC-ESI-MS/MS METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTIFICATION OF INFIGRATINIB IN BIOLOGICAL MATRICES. Int J App Pharm 2024:88
    https://doi.org/10.22159/ijap.2024v16i1.49476
  139. Dongwook Oh, Junyong Chong, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Dong‐Wan Seo, Sung Koo Lee, Myung‐Hwan Kim. The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction. J of Gastro and Hepatol 2022;37:2083
    https://doi.org/10.1111/jgh.15967
  140. Haibo Liu, Lujuan Ma, Jian Wang. Overexpression of miR‑25 is associated with progression and poor prognosis of cholangiocarcinoma. Exp Ther Med 2019
    https://doi.org/10.3892/etm.2019.7844
  141. Hayat Khizar, Yufei Hu, Yanhua Wu, Jianfeng Yang. The role and implication of autophagy in cholangiocarcinoma. Cell Death Discov. 2023;9
    https://doi.org/10.1038/s41420-023-01631-7
  142. Jin Lee, Eun Hong, Jung Kim, Jung Kim, Jang Jung, Se Park, Dong Koh. Ursodeoxycholic acid inhibits epithelial‑mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study. Oncol Lett 2022;24
    https://doi.org/10.3892/ol.2022.13568
  143. A. C. Anand. Gastroenterology and Hepatology. 2022.
    https://doi.org/10.1007/978-981-99-9287-4_6
  144. Chia-Ray Lin, Tsan-Mei Chu, Anin Luo, Shin-Jie Huang, Hsin-Yiu Chou, Ming-Wei Lu, Jen-Leih Wu. Omega-3 polyunsaturated fatty acids suppress metastatic features of human cholangiocarcinoma cells by suppressing twist. The Journal of Nutritional Biochemistry 2019;74:108245
    https://doi.org/10.1016/j.jnutbio.2019.108245
  145. Chengyu Liao, Danfeng Wang, Long Huang, Yannan Bai, Maolin Yan, Songqiang Zhou, Funan Qiu, Zhide Lai, Yaodong Wang, Yifeng Tian, Xiaochun Zheng, Shi Chen. A new strategy of laparoscopic anatomical hemihepatectomy guided by the middle hepatic vein combined with transhepatic duct lithotomy for complex hemihepatolithiasis: A propensity score matching study. Surgery 2021;170:18
    https://doi.org/10.1016/j.surg.2020.12.043
  146. Ruiyan Yuan, Yang Li, Bo Yang, Zhaohui Jin, Jiacheng Xu, Ziyu Shao, Huijie Miao, Tai Ren, Yang Yang, Guoqiang Li, Xiaoling Song, Yunping Hu, Xu’an Wang, Ying Huang, Yingbin Liu. LOXL1 exerts oncogenesis and stimulates angiogenesis through the LOXL1-FBLN5/αvβ3 integrin/FAK-MAPK axis in ICC. Molecular Therapy - Nucleic Acids 2021;23:797
    https://doi.org/10.1016/j.omtn.2021.01.001
  147. Mai Ly Thi Nguyen, Nguyen Linh Toan, Maria Bozko, Khac Cuong Bui, Przemyslaw Bozko. Cholangiocarcinoma Therapeutics: An Update. CCDT 2021;21:457
    https://doi.org/10.2174/1568009621666210204152028
  148. Chun-Ru Lin, Yu-Kwang Lee, Chun-Ju Chiang, Ya-Wen Yang, Hung-Chuen Chang, San-Lin You. Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: A population-based study. WJG 2022;28:3695
    https://doi.org/10.3748/wjg.v28.i28.3695
  149. Caitlin Hester, Ibrahim Nassour, Beverley Adams-Huet, Mathew Augustine, Michael A. Choti, Rebecca M. Minter, John C. Mansour, Patricio M. Polanco, Matthew R. Porembka, Sam C. Wang, Adam C. Yopp. Improved Survival in Surgically Resected Distal Cholangiocarcinoma Treated with Adjuvant Therapy: a Propensity Score Matched Analysis. Journal of Gastrointestinal Surgery 2018;22:2080
    https://doi.org/10.1007/s11605-018-3875-x
  150. C. S. Pitchumoni, Nishal Ravindran. Geriatric Gastroenterology. 2018.
    https://doi.org/10.1007/978-3-030-30192-7_105
  151. A. Yu. Ralnikova, V. F. Bezhenar, B. V. Arakelyan, N. A. Tatarova, M. A. Kitaeva, S. F. Bagnenko. Malignant tumors of the digestive system during pregnancy: problems of timely diagnosis. VESTNIK KHIRURGII IMENI I.I.GREKOVA 2021;179:81
    https://doi.org/10.24884/0042-4625-2020-179-5-81-86
  152. Shuhai Chen, Xiaoliang Kang, Guangwei Liu, Bingyuan Zhang, Xiao Hu, Yujie Feng. α7-Nicotinic Acetylcholine Receptor Promotes Cholangiocarcinoma Progression and Epithelial–Mesenchymal Transition Process. Dig Dis Sci 2019;64:2843
    https://doi.org/10.1007/s10620-019-05609-3
  153. Toru Yamada, Yoshitsugu Nakanishi, Hideyuki Hayashi, Shigeki Tanishima, Ryo Mori, Kyoko Fujii, Keisuke Okamura, Takahiro Tsuchikawa, Toru Nakamura, Takehiro Noji, Toshimichi Asano, Aya Matsui, Kimitaka Tanaka, Yusuke Watanabe, Yo Kurashima, Yuma Ebihara, Soichi Murakami, Toshiaki Shichinohe, Tomoko Mitsuhashi, Satoshi Hirano. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma. HPB 2022;24:1035
    https://doi.org/10.1016/j.hpb.2021.11.008
  154. Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, Suchada Phimsen, Supisara Sripramote, Jeranan Jantra, Chaiwat Choeiphuk, Somkit Mingphruedhi, Paramin Muangkaew, Narongsak Rungsakulkij, Pongsatorn Tangtawee, Wikran Suragul, Watoo Vassanasiri Farquharson, Kanokpan Wongprasert, Somchai Chutipongtanate, Pimtip Sanvarinda, Marisa Ponpuak, Naravat Poungvarin, Tavan Janvilisri, Tuangporn Suthiphongchai, Kiren Yacqub-Usman, Anna M. Grabowska, David O. Bates, Rutaiwan Tohtong. Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation. Pharmaceuticals 2024;17:197
    https://doi.org/10.3390/ph17020197
  155. Roxana-Luiza Caragut, Madalina Ilie, Teodor Cabel, Deniz Günșahin, Afrodita Panaitescu, Christopher Pavel, Oana Mihaela Plotogea, Ecaterina Mihaela Rînja, Gabriel Constantinescu, Vasile Sandru. Updates in Diagnosis and Endoscopic Management of Cholangiocarcinoma. Diagnostics 2024;14:490
    https://doi.org/10.3390/diagnostics14050490
  156. Yong Wang, Zhongran Man, Xiaosi Hu, Lei Zhou, Hao Jin, Huichun Liu, Qing Pang. Percutaneous biliary stent with intraluminal brachytherapy versus palliative surgery in the management of extrahepatic cholangiocarcinoma. Int J Clin Oncol 2021;26:933
    https://doi.org/10.1007/s10147-021-01877-0
  157. Nazli Begüm Öztürk, Laith H. Jamil. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma. 2024;36:766
    https://doi.org/10.1097/MEG.0000000000002761
  158. Nesil Yalman. LMCD1 antisense RNA 1 is a newly identified long noncoding RNA. 2022;33:1
    https://doi.org/10.1097/CAD.0000000000001124
  159. Chaobo Chen, Leonard J. Nelson, Matías A. Ávila, Francisco Javier Cubero. Mitogen-Activated Protein Kinases (MAPKs) and Cholangiocarcinoma: The Missing Link. Cells 2019;8:1172
    https://doi.org/10.3390/cells8101172
  160. Mumtaz Niazi, Pratik A. Shukla, Nikolaos Pyrsopoulos. Geriatric Gastroenterology. 2019.
    https://doi.org/10.1007/978-3-319-90761-1_51-1
  161. Morimoto Koichiro, Ueda Hiroki, Asano Daisuke, Ishikawa Yoshiiya, Watanabe Shuichi, Akahoshi Keiichi, Ono Hiroaki, Kobayashi Masanori, Okamoto Ryuichi, Tanaka Shinji, Tanabe Minoru. Incidence and Mechanism of Refractory Postoperative Cholangitis After Hepatectomy with Hepaticojejunostomy. Journal of Gastrointestinal Surgery 2023;27:1668
    https://doi.org/10.1007/s11605-023-05724-7
  162. Samantha M. Ruff, Mary Dillhoff. Review of IDH mutations and potential therapies for intrahepatic cholangiocarcinoma. Hepatoma Res 2023
    https://doi.org/10.20517/2394-5079.2023.51
  163. Sheng Han, Dong Wang, Guohua Tang, Xinxiang Yang, Chenyu Jiao, Renjie Yang, Yaodong Zhang, Liqun Huo, Zicheng Shao, Zefa Lu, Jiawei Zhang, Xiangcheng Li. Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma. Oncotarget 2017;8:56635
    https://doi.org/10.18632/oncotarget.17832
  164. Marika Reinius, Edmund Godfrey, Bristi Basu. Imaging for Clinical Oncology. 2017.
    https://doi.org/10.1093/med/9780198818502.003.0009
  165. Jung Wan Choe. Approach to the Patients with Elevated CA 19-9. Korean J Gastroenterol 2023;81:185
    https://doi.org/10.4166/kjg.2023.042
  166. Hao Ji, Juan Wang, Binbin Lu, Juan Li, Jing Zhou, Li Wang, Shufen Xu, Peng Peng, Xuezhen Hu, Keming Wang. SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A. Mol Med 2021;27
    https://doi.org/10.1186/s10020-020-00222-x
  167. Minxiao Chen, Chenchen Qian, Bo Jin, Chenghong Hu, Lingxi Zhang, Minshan Wang, Bin Zhou, Wei Zuo, Lijiang Huang, Yi Wang. Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma. Cancer Biology & Therapy 2023;24
    https://doi.org/10.1080/15384047.2022.2162807
  168. Consolato M. Sergi. Liver Cancer. 2023.
    https://doi.org/10.36255/exonpublications.livercancer.2021.ch1
  169. Rogier Baak, François Willemssen, Yvette van Norden, Ferry Eskens, Maaike Milder, Ben Heijmen, Bas Koerkamp, Dave Sprengers, Lydi van Driel, Heinz-Josef Klümpen, Wilhelm den Toom, Merel Koedijk, Jan IJzermans, Alejandra Méndez Romero. Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study. Cancers 2021;13:3991
    https://doi.org/10.3390/cancers13163991
  170. Yoshihiro Shioi, Mitsumasa Osakabe, Naoki Yanagawa, Hiroyuki Nitta, Akira Sasaki, Tamotsu Sugai. Analysis of Somatic Copy Number Alterations in Biliary Tract Carcinoma Using a Single Nucleotide Polymorphism Array. Future Sci. OA 2022;8
    https://doi.org/10.2144/fsoa-2021-0057
  171. Shuang-Shuang Guo, Ying Wang, Qing-Xia Fan. Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells. WJG 2019;25:3380
    https://doi.org/10.3748/wjg.v25.i26.3380
  172. Lin Zhou, Xiaohong Deng, Xiulin Xiao, Yonghui Liao, Wenhui Chen, Qixin Dai. Kruppel-like factor 9 inhibits growth and metastasis of cholangiocarcinoma cells by targeted regulation of metallothionein 1 M transcription. Tissue and Cell 2022;79:101962
    https://doi.org/10.1016/j.tice.2022.101962
  173. Qiao Wu, Hua Fan, Ren Lang, Xianliang Li, Xingmao Zhang, Shaocheng Lv, Qiang He, Jialiang Yang. [Retracted] Overexpression of 14‐3‐3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling. BioMed Research International 2020;2020
    https://doi.org/10.1155/2020/3740418
  174. Gamal A.E. Mostafa, Adnan A. Kadi, Najla AlMasoud, Mohamed W. Attwa, Nasser S. Al-Shakliah, Haitham AlRabiah. LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes. Journal of Chromatography B 2021;1179:122806
    https://doi.org/10.1016/j.jchromb.2021.122806
  175. Liu Tian, Zhanjun Lu, Lei Lei, Ning Yang, Zhaoyang Chen, Beike Lu, Zhu Jin, Yuanyuan Shen, Shengrong Guo. Preparation, characterization and primary evaluation of trilayered biliary stent films for anti-cholangiocarcinoma and anti-biofilm formation. International Journal of Pharmaceutics 2021;606:120869
    https://doi.org/10.1016/j.ijpharm.2021.120869
  176. Eugene J. Koay, Milind Javle, Madeline Belknap, Shrey Derasari, Millicent Roach, Ethan B. Ludmir. What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?. Cancer J 2023;29:272
    https://doi.org/10.1097/PPO.0000000000000685
  177. Dan Høgdall, Ole F. Larsen, Dorte Linnemann, Tim Svenstrup Poulsen, Estrid V. Høgdall. Exome sequencing of 22 genes using tissue from patients with biliary tract cancer. APMIS 2020;128:3
    https://doi.org/10.1111/apm.13003
  178. Reem J. Abdualmjid, Consolato M. Sergi. Mitochondrial Dysfunction and Induction of Apoptosis in Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines by Thymoquinone. IJMS 2022;23:14669
    https://doi.org/10.3390/ijms232314669
  179. Kishor Pant, Seth Richard, Estanislao Peixoto, Jun Yin, Davis M. Seelig, Pietro Carotenuto, Massimiliano Salati, Brunella Franco, Lewis R. Roberts, Sergio A. Gradilone. The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth. Cells 2023;12:775
    https://doi.org/10.3390/cells12050775
  180. Yanhua Zhang, Jingfeng Luo, Xue Dong, Fang Yang, Miaofeng Zhang, Juanjuan Zhao, Qiangfeng Wang, Fei Zhou, Jihong Sun, Xiaoming Yang. Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines. Ann Surg Oncol 2019;26:4134
    https://doi.org/10.1245/s10434-019-07649-5
  181. Chiao-En Wu, Chen-Yang Huang, Chiao-Ping Chen, Yi-Ru Pan, John Wen-Cheng Chang, Jen-Shi Chen, Chun-Nan Yeh, John Lunec. WIP1 Inhibition by GSK2830371 Potentiates HDM201 through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021;13:3876
    https://doi.org/10.3390/cancers13153876
  182. Thanich Sangsuwannukul, Kamonlapat Supimon, Jatuporn Sujjitjoon, Nattaporn Phanthaphol, Thaweesak Chieochansin, Naravat Poungvarin, Sopit Wongkham, Mutita Junking, Pa-thai Yenchitsomanus. Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells. International Immunopharmacology 2020;89:107069
    https://doi.org/10.1016/j.intimp.2020.107069
  183. Bo‐Hao Zheng, Sheng Shen, Kwong‐Fai Wong, Zi‐Jun Gong, Wen‐Tao Sun, Xiao‐Jian Ni, Ji‐Wen Wang, Mei‐Yu Hu, Han Liu, Xiao‐Ling Ni, Hou‐Bao Liu, John M. Luk, Tao Suo. Clinical correlation of cadherin‐17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma. Journal of Surgical Oncology 2021;123:1253
    https://doi.org/10.1002/jso.26399
  184. Tudor Mocan, Adelina Horhat, Emil Mois, Florin Graur, Cristian Tefas, Rares Craciun, Iuliana Nenu, Mihaela Spârchez, Zeno Sparchez. Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?. WJGO 2021;13:2050
    https://doi.org/10.4251/wjgo.v13.i12.2050
  185. Dongyou Liu. Tumors and Cancers. 2021.
    https://doi.org/10.1201/b22275-24
  186. Paul J. Kelly. Histopathology Reporting. 2021.
    https://doi.org/10.1007/978-3-030-27828-1_10
  187. Sureerat Padthaisong, Malinee Thanee, Nisana Namwat, Jutarop Phetcharaburanin, Poramate Klanrit, Narong Khuntikeo, Attapol Titapun, Sakkarn Sungkhamanon, Hideyuki Saya, Watcharin Loilome. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. J Transl Med 2020;18
    https://doi.org/10.1186/s12967-020-02243-w
  188. A. Yu. Ralnikova, V. F. Bezhenar, B. V. Arakelyan, N. A. Tatarova, M. E. Malysheva. Cholangiocarcinoma in pregnancy (clinical case). 2020:19
    https://doi.org/10.33920/med-15-2006-03
  189. Luis Carlos Hinojosa Arco, Jorge Francisco Roldán de la Rúa, Isabel Arranz Salas, Rocío Gómez Pérez, Miguel Ángel Suárez Muñoz. Inflammatory myofibroblastic tumor of the liver mimicking Klatskin tumor. Cirugía Española (English Edition) 2023;101:303
    https://doi.org/10.1016/j.cireng.2022.05.008
  190. Milind Javle, Sunyoung Lee, Nilofer S Azad, Mitesh J Borad, Robin Kate Kelley, Smitha Sivaraman, Anna Teschemaker, Ishveen Chopra, Nora Janjan, Shreekant Parasuraman, Tanios S Bekaii-Saab. Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017. 2022;27:874
    https://doi.org/10.1093/oncolo/oyac150
  191. Hoonsub So, Chi Hyuk Oh, Tae Jun Song, Sung Woo Ko, Jun Seong Hwang, Dongwook Oh, Do Hyun Park, Sang Soo Lee, Dong-Wan Seo, Seok Ho Dong, Sung Koo Lee, Myung-Hwan Kim, Gianfranco D. Alpini. Predictors of stent dysfunction in patients with bilateral metal stents for malignant hilar obstruction. PLoS ONE 2021;16:e0249096
    https://doi.org/10.1371/journal.pone.0249096
  192. Chunmei Yang, Mengping Huang, Shupan Li, Jianqiang Chen, Yao Yang, Na Qin, Deqing Huang, Jian Shu. Radiomics model of magnetic resonance imaging for predicting pathological grading and lymph node metastases of extrahepatic cholangiocarcinoma. Cancer Letters 2020;470:1
    https://doi.org/10.1016/j.canlet.2019.11.036
  193. Luca Maroni, Marco Marzioni. Diagnosis and Management of Cholangiocarcinoma. 2020.
    https://doi.org/10.1007/978-3-030-70936-5_26
  194. Jun Zhou, Haoran Yu, Hong Zeng, Qin shen, Xuewen Wang, Qinxin Xia. Intrahepatic cholangiocarcinoma with FGFR alterations: A series of Chinese cases with an emphasis on their clinicopathologic and genetic features. Digestive and Liver Disease 2024
    https://doi.org/10.1016/j.dld.2024.04.025
  195. Shuming Wang, Yilin Hu, Xiurui Lv, Bin Li, Dianhua Gu, Yang Li, Yong Sun, Yang Su. Circ-0000284 arouses malignant phenotype of cholangiocarcinoma cells and regulates the biological functions of peripheral cells through cellular communication. 2019;133:1935
    https://doi.org/10.1042/CS20190589
  196. Yunghun You, Jin S. Heo, Sang H. Shin, Sung W. Shin, Hong S. Park, Kwang B. Park, Sung K. Cho, Dongho Hyun, In W. Han. Optimal timing of portal vein embolization (PVE) after preoperative biliary drainage for hilar cholangiocarcinoma. HPB 2022;24:635
    https://doi.org/10.1016/j.hpb.2021.09.011
  197. Christian Möhring, Oliver Khan, Taotao Zhou, Farsaneh Sadeghlar, Robert Mahn, Dominik J. Kaczmarek, Leona Dold, Marieta Toma, Milka Marinova, Tim R. Glowka, Hanno Matthaei, Steffen Manekeller, Jörg C. Kalff, Christian P. Strassburg, Tobias J. Weismüller, Maria A. Gonzalez-Carmona. Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy. Front. Oncol. 2023;13
    https://doi.org/10.3389/fonc.2023.1227036
  198. Arianeb Mehrabi, Mohammad Golriz, Ali Ramouz, Elias Khajeh, Ahmed Hammad, Thilo Hackert, Beat Müller-Stich, Oliver Strobel, Sadeq Ali-Hasan-Al-Saegh, Omid Ghamarnejad, Mohammed Al-Saeedi, Christoph Springfeld, Christian Rupp, Philipp Mayer, Markus Mieth, Benjamin Goeppert, Katrin Hoffmann, Markus W. Büchler. Promising Outcomes of Modified ALPPS for Staged Hepatectomy in Cholangiocarcinoma. Cancers 2023;15:5613
    https://doi.org/10.3390/cancers15235613
  199. Jingwei Liu, Weixin Liu, Hao Li, Qiuping Deng, Meiqi Yang, Xuemei Li, Zeng Liang. Identification of key genes and pathways associated with cholangiocarcinoma development based on weighted gene correlation network analysis. 2019;7:e7968
    https://doi.org/10.7717/peerj.7968
  200. Fabio Frosio, Federico Mocchegiani, Grazia Conte, Enrico Dalla Bona, Andrea Vecchi, Daniele Nicolini, Marco Vivarelli. Neoadjuvant therapy in the treatment of hilar cholangiocarcinoma: Review of the literature. WJGS 2019;11:279
    https://doi.org/10.4240/wjgs.v11.i6.279
  201. Nora Schweitzer, Martha M. Kirstein, Anna‐Maria Kratzel, Young‐Seon Mederacke, Mareike Fischer, Michael P. Manns, Arndt Vogel. Second‐line chemotherapy in biliary tract cancer: Outcome and prognostic factors. Liver International 2019;39:914
    https://doi.org/10.1111/liv.14063
  202. Ludovica Ceci, Tianhao Zhou, Ilaria Lenci, Vik Meadows, Lindsey Kennedy, Ping Li, Burcin Ekser, Martina Milana, Wenjun Zhang, Chaodong Wu, Keisaku Sato, Sanjukta Chakraborty, Shannon S. Glaser, Heather Francis, Gianfranco Alpini, Leonardo Baiocchi. Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development. Cancers 2022;14:1442
    https://doi.org/10.3390/cancers14061442
  203. Zai-Fa Hong, Wen-Qing Zhang, Shuang-Jia Wang, Si-Yang Li, Jin Shang, Fan Liu, Dong-Yan Shen. Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma. Biomedicine & Pharmacotherapy 2020;123:109766
    https://doi.org/10.1016/j.biopha.2019.109766
  204. . .
    https://doi.org/
  205. Ningyu Wang, Ai Huang, Bohua Kuang, Yu Xiao, Yong Xiao, Hong Ma. Progress in Radiotherapy for Cholangiocarcinoma. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.868034
  206. Ya-Fei Hu, Hai-Jie Hu, Tian-Run Lv, Zhi-Qiang He, Yu-Shi Dai, Fu-Yu Li. Should more aggressive surgical resection be considered in the treatment for Bismuth types I and II hilar cholangiocarcinoma? A meta-analysis. Asian Journal of Surgery 2023;46:4115
    https://doi.org/10.1016/j.asjsur.2022.12.043
  207. Ammar Sarwar, Aamir Ali, Damir Ljuboja, Jeffrey L. Weinstein, Anuradha S. Shenoy-Bhangle, Imad A. Nasser, Matthew K. Morrow, Salomao Faintuch, Michael P. Curry, Andrea J. Bullock, Muneeb Ahmed. Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic Cholangiocarcinoma. Journal of Vascular and Interventional Radiology 2021;32:1560
    https://doi.org/10.1016/j.jvir.2021.08.009
  208. Luis Carlos Hinojosa Arco, Jorge Francisco Roldán de la Rúa, Isabel Arranz Salas, Rocío Gómez Pérez, Miguel Ángel Suárez Muñoz. Tumor miofibroblástico inflamatorio hepático que mimetiza un tumor de Klatskin. Cirugía Española 2023;101:303
    https://doi.org/10.1016/j.ciresp.2022.04.004
  209. Hector Perez-Montoyo. Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma. Cells 2020;9:614
    https://doi.org/10.3390/cells9030614
  210. Kristen Bibeau, Tara D Jackson, Melinda Bachini, Anouk Lindley, Fernando Blanco, Christine LaFiura, Haobo Ren, Stacie Lindsey. Diagnostic journey and life impact of cholangiocarcinoma: results from surveys of patient and caregiver experiences. Future Oncol. 2024;20:997
    https://doi.org/10.2217/fon-2023-0151
  211. Giuliano LA BARBA, Carlo Alberto PACILIO, Cecilia BINDA, Francesca FAPPIANO, Carlo FABBRI, Giorgio ERCOLANI. INTRAHEPATIC BILIARY STRICTURES WITH UNDERLYING PRE-MALIGNANT BILIARY LESIONS: IS IT TIME TO BUILD GUIDELINES ON DIAGNOSIS AND MANAGEMENT?. ABCD, arq. bras. cir. dig. 2021;34
    https://doi.org/10.1590/0102-672020210002e1613
  212. Na Su, Wubulitalifu Dawuti, Yan Hu, Hui Zhao. Noninvasive cholangitis and cholangiocarcinoma screening based on serum Raman spectroscopy and support vector machine. Photodiagnosis and Photodynamic Therapy 2022;40:103156
    https://doi.org/10.1016/j.pdpdt.2022.103156
  213. Chi-Chih Wang, Ming-Hseng Tseng, Sheng-Wen Wu, Tzu-Wei Yang, Hsuan-Yi Chen, Wen-Wei Sung, Chang-Cheng Su, Yao-Tung Wang, Chun-Che Lin, Ming-Chang Tsai. Cholecystectomy reduces subsequent cholangiocarcinoma risk in choledocholithiasis patients undergoing endoscopic intervention. WJGO 2020;12:1381
    https://doi.org/10.4251/wjgo.v12.i12.1381
  214. Iswanto Sucandy, Emanuel Shapera, Kevin Jacob, Kenneth Luberice, Kaitlyn Crespo, Cameron Syblis, Sharona B. Ross, Alexander S. Rosemurgy. Robotic resection of extrahepatic cholangiocarcinoma: Institutional outcomes of bile duct cancer surgery using a minimally invasive technique. Journal of Surgical Oncology 2022;125:161
    https://doi.org/10.1002/jso.26674
  215. Atsushi Maeda, Sho Goto, Ryota Iwasaki, Koji Yamada, Mami Murakami, Hiroki Sakai, Takashi Mori. Outcome of Localized Bile Duct Carcinoma in Six Dogs Treated with Liver Lobectomy. 2022;58:189
    https://doi.org/10.5326/JAAHA-MS-7199
  216. Preawwalee Wintachai, Jing Quan Lim, Anchalee Techasen, Worachart Lert-itthiporn, Sarinya Kongpetch, Watcharin Loilome, Jarin Chindaprasirt, Attapol Titapun, Nisana Namwat, Narong Khuntikeo, Apinya Jusakul. Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma. Diagnostics 2021;11:999
    https://doi.org/10.3390/diagnostics11060999
  217. Junya Toyoda, Kota Sahara, Shishir K. Maithel, Daniel E. Abbott, George A. Poultsides, Christopher Wolfgang, Ryan C. Fields, Jin He, Charles Scoggins, Kamran Idrees, Perry Shen, Itaru Endo, Timothy M. Pawlik. Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium. Ann Surg Oncol 2022;29:7605
    https://doi.org/10.1245/s10434-022-12058-2
  218. Nicholas S. Samel, Hiroshi Mashimo. Application of OCT in the Gastrointestinal Tract. Applied Sciences 2019;9:2991
    https://doi.org/10.3390/app9152991
  219. Ghassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, Robin K Kelley, Sam J Lubner, Jorge Adeva, James M Cleary, Daniel V Catenacci, Mitesh J Borad, John Bridgewater, William P Harris, Adrian G Murphy, Do-Youn Oh, Jonathan Whisenant, Maeve A Lowery, Lipika Goyal, Rachna T Shroff, Anthony B El-Khoueiry, Bin Fan, Bin Wu, Christina X Chamberlain, Liewen Jiang, Camelia Gliser, Shuchi S Pandya, Juan W Valle, Andrew X Zhu. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. The Lancet Oncology 2020;21:796
    https://doi.org/10.1016/S1470-2045(20)30157-1
  220. Benchen Rao, Tong Ren, Xuemei Wang, Haiyu Wang, Yawen Zou, Ying Sun, Shanshuo Liu, Zhigang Ren, Zujiang Yu. Dysbiosis in the Human Microbiome of Cholangiocarcinoma. Front. Physiol. 2021;12
    https://doi.org/10.3389/fphys.2021.715536
  221. Rittibet Yapasert, Nirush Lertprasertsuk, Subhawat Subhawa, Juthathip Poofery, Bungorn Sripanidkulchai, Ratana Banjerdpongchai. Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo. IJMS 2020;21:5669
    https://doi.org/10.3390/ijms21165669
  222. Heithem Jeddou, Stylianos Tzedakis, Francesco Orlando, Antoine Robert, Eric Meneyrol, Damien Bergeat, Fabien Robin, Laurent Sulpice, Karim Boudjema. Liver Resection for Type IV Perihilar Cholangiocarcinoma: Left or Right Trisectionectomy?. Cancers 2022;14:2791
    https://doi.org/10.3390/cancers14112791
  223. Chengzhi Zhang, Mengyao Song, Zhanguo Sun, Yi Fang, Yiming Liu, Kaihao Xu, Xinwei Han, Dechao Jiao. Biliary drainage combined with simultaneous 125I seed strand brachytherapy for the treatment of hilar cholangiocarcinoma. BMC Cancer 2023;23
    https://doi.org/10.1186/s12885-023-10868-5
  224. Jianqiao Peng, Yi Xiang. Value analysis of CD69 combined with EGR1 in the diagnosis of coronary heart disease. Exp Ther Med 2019
    https://doi.org/10.3892/etm.2019.7175
  225. Nicole Cheng, Nathanelle Khoo, Alexander Y. F. Chung, Brian K. P. Goh, Peng Chung Cheow, Pierce K. H. Chow, Ser Yee Lee, London L. Ooi, Prema Raj Jeyaraj, Juinn Huar Kam, Ye Xin Koh, Chung Yip Chan, Jin Yao Teo. Pre‐operative Imaging Characteristics in Histology‐Proven Resected Intrahepatic Cholangiocarcinoma. World j. surg. 2020;44:3862
    https://doi.org/10.1007/s00268-020-05698-6
  226. Mario Rizzato, Stefano Brignola, Giada Munari, Maura Gatti, Vincenzo Dadduzio, Chiara Borga, Francesca Bergamo, Antonio Pellino, Valentina Angerilli, Claudia Mescoli, Maria Guido, Jessica Rearden, Enrico Gringeri, Umberto Cillo, Angelo Paolo Dei Tos, Vittorina Zagonel, Fotios Loupakis, Sara Lonardi, Matteo Fassan. Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study. European Journal of Cancer 2022;166:165
    https://doi.org/10.1016/j.ejca.2022.02.013
  227. Akpunonu Chinaemelum, Muhammad Musaab Munir, Lovette Azap, Selamawit Woldesenbet, Mary Dillhoff, Jordan Cloyd, Aslam Ejaz, Timothy M. Pawlik. Impact of Food Insecurity on Outcomes Following Resection of Hepatopancreaticobiliary Cancer. Ann Surg Oncol 2023;30:5365
    https://doi.org/10.1245/s10434-023-13723-w
  228. Emma Lodl, Brian Ramnaraign, Ilyas Sahin, Sarah Wheeler. Updates in the use of targeted therapies for the treatment of cholangiocarcinoma. J Oncol Pharm Pract 2023;29:1206
    https://doi.org/10.1177/10781552231171079
  229. Shun He, Fanxin Zeng, Huihui Yin, Pei Wang, Yinlei Bai, Qianqian Song, Jiangtao Chu, Zhen Huang, Yumeng Liu, Hong Liu, Qichen Chen, Li Liu, Jun Zhou, Hanjie Hu, Xingchen Li, Tengyan Li, Guiqi Wang, Jianqiang Cai, Yuchen Jiao, Hong Zhao. Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples. eClinicalMedicine 2023;55:101736
    https://doi.org/10.1016/j.eclinm.2022.101736
  230. Omid Kooshkaki, Zohre Rezaei, Meysam Rahmati, Parviz Vahedi, Afshin Derakhshani, Oronzo Brunetti, Amir Baghbanzadeh, Behzad Mansoori, Nicola Silvestris, Behzad Baradaran. MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers. IJMS 2020;21:2578
    https://doi.org/10.3390/ijms21072578
  231. Richard Tang, Nicholas Latchana, Amir A. Rahnemai-Azar, Timothy M. Pawlik. Primary and Metastatic Liver Tumors. 2020.
    https://doi.org/10.1007/978-3-319-91977-5_8
  232. Bobak Moazzami, Keivan Majidzadeh-A, Arash Dooghaie-Moghadam, Pegah Eslami, Niloofar Razavi-Khorasani, Shahrokh Iravani, Alireza Khoshdel, Farhad Shahi, Habibolah Dashti, Azim Mehrvar, Mohssen Nassiri Toosi. Cholangiocarcinoma: State of the Art. J Gastrointest Canc 2020;51:774
    https://doi.org/10.1007/s12029-020-00390-3
  233. Shihai Yang, Qihua Wu, Qi Wang, Fajin Lv, Ahmed Faeq Hussein. Magnetic Resonance Imaging under Image Enhancement Algorithm to Analyze the Clinical Value of Placement of Drainage Tube on Incision Healing after Hepatobiliary Surgery. Computational and Mathematical Methods in Medicine 2022;2022:1
    https://doi.org/10.1155/2022/9269695
  234. Cheng Chen, Zhi-Peng Liu, Wei-Yue Chen, Xiang Wang, Yun-Hua Liu, Yue Wang, Xing-Chao Liu, Hai-Ning Fan, Jie Bai, Yan Jiang, Yan-Qi Zhang, Hai-Su Dai, Zhi-Yu Chen. Anatomical hepatectomy for achieving textbook outcome for perihilar cholangiocarcinoma treated with curative-intent resection: A multicenter study. iLIVER 2022;1:245
    https://doi.org/10.1016/j.iliver.2022.10.004
  235. Alessandra Gentilini, Mirella Pastore, Fabio Marra, Chiara Raggi. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium. IJMS 2018;19:2885
    https://doi.org/10.3390/ijms19102885
  236. Daljeet Chahal, Chris Shamatutu, Bill Salh, Janine Davies. The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival. JGH Open 2020;4:1128
    https://doi.org/10.1002/jgh3.12405
  237. Raksawan Deenonpoe, Prakasit Sa-ngiamwibool, Sasithorn Watcharadetwittaya, Malinee Thanee, Kitti Intuyod, Thachanan Kongpan, Sureerat Padthaisong, Rungtiwa Nutalai, Yaovalux Chamgramol, Chawalit Pairojkul. Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma. Sci Rep 2022;12
    https://doi.org/10.1038/s41598-022-11945-8
  238. Alexandra Jifcovici, Johan Caraty, Gaëlle Vincken, Alexandre Bongartz. End‐to‐end anastomosis of the common bile duct and cholecystoduodenostomy for the treatment of extrahepatic cholangiocarcinoma in an 11‐year‐old cat. Vet Record Case Reports 2021;9
    https://doi.org/10.1002/vrc2.161
  239. Arnaud Hocquelet, Charalampos Sotiriadis, Rafael Duran, Boris Guiu, Takamune Yamaguchi, Nermin Halkic, Emmanuel Melloul, Nicolas Demartines, Alban Denys. Preoperative Portal Vein Embolization Alone with Biliary Drainage Compared to a Combination of Simultaneous Portal Vein, Right Hepatic Vein Embolization and Biliary Drainage in Klatskin Tumor. Cardiovasc Intervent Radiol 2018;41:1885
    https://doi.org/10.1007/s00270-018-2075-0
  240. Nittaya Chamadol, Richard Syms, Vallop Laopaiboon, Julaluck Promsorn, Kulyada Eurboonyanun. Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. 2018.
    https://doi.org/10.1007/978-3-031-35166-2_6
  241. Wenzhi Li, Zhe Sun, Chen Chen, Lin Wang, Zhimin Geng, Jie Tao. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells. Biomedicine & Pharmacotherapy 2018;100:257
    https://doi.org/10.1016/j.biopha.2018.02.007
  242. H.-M. Tautenhahn, S. Brückner, F. Rauchfuß, F. Donndorf, M. Ardelt, R. Fahrner, A. Tannapfel, U. Settmacher. Präkanzerosen und Frühkarzinome des Gallengangsystems. Chirurg 2018;89:274
    https://doi.org/10.1007/s00104-017-0553-6
  243. Merel S Koedijk, Ben J M Heijmen, Bas Groot Koerkamp, Ferry A L M Eskens, Dave Sprengers, Jan-Werner Poley, Dik C van Gent, Luc J W van der Laan, Bronno van der Holt, François E J A Willemssen, Alejandra Méndez Romero. Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study. BMJ Open 2018;8:e020731
    https://doi.org/10.1136/bmjopen-2017-020731
  244. Defne Bayik, Adam J. Lauko, Gustavo A. Roversi, Emily Serbinowski, Lou-Anne Acevedo-Moreno, Christopher Lanigan, Mushfig Orujov, Alice Lo, Tyler J. Alban, Adam Kim, Daniel J. Silver, Laura E. Nagy, J. Mark Brown, Daniela S. Allende, Federico N. Aucejo, Justin D. Lathia. Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles. Sci Rep 2020;10
    https://doi.org/10.1038/s41598-020-75881-1
  245. Margherita Rimini, Marco Puzzoni, Federica Pedica, Nicola Silvestris, Lorenzo Fornaro, Giuseppe Aprile, Eleonora Loi, Oronzo Brunetti, Caterina Vivaldi, Francesca Simionato, Patrizia Zavattari, Mario Scartozzi, Valentina Burgio, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini. Cholangiocarcinoma: new perspectives for new horizons. Expert Review of Gastroenterology & Hepatology 2021;15:1367
    https://doi.org/10.1080/17474124.2021.1991313
  246. Meng-yu Zhang, Jie-ping Wang, Kai He, Xian-ming Xia. Bsep expression in hilar cholangiocarcinoma of rat model. Sci Rep 2021;11
    https://doi.org/10.1038/s41598-021-82636-z
  247. Nathalie Guedj. Pathology of Cholangiocarcinomas. Current Oncology 2022;30:370
    https://doi.org/10.3390/curroncol30010030
  248. Alberto Zanetto, Sarah Shalaby, Martina Gambato, Giacomo Germani, Marco Senzolo, Debora Bizzaro, Francesco Paolo Russo, Patrizia Burra. New Indications for Liver Transplantation. JCM 2021;10:3867
    https://doi.org/10.3390/jcm10173867
  249. Edwin Leopoldo Maldonado-García, Antonio Urbina-Zeglen, José Luis Maldonado-Calderón. Colangiocarcinoma. Caso clínico a propósito del abordaje diagnóstico. 2022;44:34
    https://doi.org/10.35366/109317
  250. Keiichiro Yokota, Satoshi Serada, Shigehiro Tsujii, Keisuke Toya, Tsuyoshi Takahashi, Takashi Matsunaga, Minoru Fujimoto, Sunao Uemura, Tsutomu Namikawa, Ichiro Murakami, Shogo Kobayashi, Hidetoshi Eguchi, Yuichiro Doki, Kazuhiro Hanazaki, Tetsuji Naka. Anti-Glypican-1 Antibody–drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1–Positive Cholangiocarcinoma. 2021;20:1713
    https://doi.org/10.1158/1535-7163.MCT-21-0015
  251. Katiuscha Merath, Ankur Tiwari, Alexander A Parikh, Timothy M Pawlik. Molecular Targeted and Systemic Therapy for Intrahepatic Cholangiocarcinoma: a Multi-Disciplinary Approach. Future Oncol. 2023;19:2607
    https://doi.org/10.2217/fon-2023-0098
  252. Anitha James. Focal lesions of the liver: imaging appearances and management. Br J Hosp Med 2020;81:1
    https://doi.org/10.12968/hmed.2019.0395
  253. Sitthinon Siripanthong, Anchalee Techasen, Chanin Nantasenamat, Aijaz Ahmad Malik, Paiboon Sithithaworn, Chanvit Leelayuwat, Amonrat Jumnainsong, Theerapong Krajaejun. Production and characterization of antibody against Opisthorchis viverrini via phage display and molecular simulation. PLoS ONE 2021;16:e0248887
    https://doi.org/10.1371/journal.pone.0248887
  254. Nasser S. Al-Shakliah, Mohamed W. Attwa, Adnan A. Kadi, Haitham AlRabiah. Identification and characterization of in silico, in vivo, in vitro, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites. RSC Adv. 2020;10:16231
    https://doi.org/10.1039/C9RA10871H
  255. Gábor Lendvai, Tímea Szekerczés, Ildikó Illyés, Milán Csengeri, Krisztina Schlachter, Erzsébet Szabó, Gábor Lotz, András Kiss, Katalin Borka, Zsuzsa Schaff, Vladimir Trajkovic. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor. PLoS ONE 2021;16:e0253065
    https://doi.org/10.1371/journal.pone.0253065
  256. Guanran Zhang, Xuyue Liu, Zhengyang Sun, Xiaoning Feng, Haiyan Wang, Jing Hao, Xiaoli Zhang. A2M is a potential core gene in intrahepatic cholangiocarcinoma. BMC Cancer 2022;22
    https://doi.org/10.1186/s12885-021-09070-2
  257. M. Maßmann, J. Treckmann, P. Markus, B. Schumacher, D. Albers, S. Ting, B. Mende, J. Roehrle, I. Virchow, V. Rosery, K. Laue, G. Zaun, K. Kostbade, M. Pogorzelski, K. W. Schmid, H. Baba, J. T. Siveke, A. Paul, H. U. Schildhaus, M. Schuler, M. Wiesweg, S. Kasper. A prognostic systemic inflammation score (SIS) in patients with advanced intrahepatic cholangiocarcinoma. J Cancer Res Clin Oncol 2023;149:5085
    https://doi.org/10.1007/s00432-022-04424-0
  258. Chunfu Wang, Songmao Liang, Jiachen Xu, Yingfan Zhai, Jianghui Chen, Xiangjun Qiu. The Effect of Yinchenhao Decoction on the Pharmacokinetic Profile of Futibatinib by HPLC-MS/MS. Separations 2024;11:213
    https://doi.org/10.3390/separations11070213
  259. Piyanard Boonnate, Kulthida Vaeteewoottacharn, Ryusho Kariya, Sawako Fujikawa, Thidarut Boonmars, Somchai Pinlaor, Chawalit Pairojkul, Seiji Okada. Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases. In Vitro Cell.Dev.Biol.-Animal 2021;57:825
    https://doi.org/10.1007/s11626-021-00608-z
  260. Zengli Liu, Chunxiao Hu, Lijie Zheng, Jialiang Liu, Kangshuai Li, Xingyong Li, Yue Wang, Wentao Mu, Tianli Chen, Anda Shi, Bo Qiu, Xin Zhang, Zongli Zhang, Yunfei Xu. BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner. Cell. Mol. Life Sci. 2022;79
    https://doi.org/10.1007/s00018-022-04500-1
  261. Qing He, Yingxuan Yin, Xiaowen Pan, Yinjuan Wu, Xuerong Li. Albendazole-induced autophagy blockade contributes to elevated apoptosis in cholangiocarcinoma cells through AMPK/mTOR activation. Toxicology and Applied Pharmacology 2022;454:116214
    https://doi.org/10.1016/j.taap.2022.116214
  262. Sinead Cremen, Michael E. Kelly, Tom K. Gallagher. The role of neo-adjuvant therapy in cholangiocarcinoma: A systematic review. Front. Oncol. 2022;12
    https://doi.org/10.3389/fonc.2022.975136
  263. Michael J. Viereckl, Kelsey Krutsinger, Aaron Apawu, Jian Gu, Bryana Cardona, Donovan Barratt, Yuyan Han. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways. Biomolecules 2022;12:854
    https://doi.org/10.3390/biom12060854
  264. Jan Holubar, Virginie Bres, Valérie Costes-Martineau, Yves-Marie Pers. Cholangiocarcinoma occurring in a patient with type 1 Gaucher disease treated with velaglucerase alfa enzyme replacement therapy: First case report. Blood Cells, Molecules, and Diseases 2018;68:112
    https://doi.org/10.1016/j.bcmd.2017.05.010
  265. Samuel C. Fehling, Aubrey L. Miller, Patrick L. Garcia, Rebecca B. Vance, Karina J. Yoon. The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma. Cancer Letters 2020;468:48
    https://doi.org/10.1016/j.canlet.2019.10.011
  266. Paolo Magistri, Ning Qi Pang, Cristiano Guidetti, Daniela Caracciolo, Roberta Odorizzi, Barbara Catellani, Gian Piero Guerrini, Stefano Di Sandro, Fabrizio Di Benedetto. Robotic approach for perihilar cholangiocarcinoma: from Bismuth 1 to vascular resection. European Journal of Surgical Oncology 2023;49:107002
    https://doi.org/10.1016/j.ejso.2023.107002
  267. Zuxiao Chen, Xiaofeng Jiang, Ping Xue, Shaoyi Chen, Shiying Li, Zongyan Li, Weidong Pan, Dawei Zhang. Long-term efficacy of percutaneous transhepatic cholangioscopy-guided photodynamic therapy for postoperative recurrent extrahepatic cholangiocarcinoma. Photodiagnosis and Photodynamic Therapy 2022;40:103122
    https://doi.org/10.1016/j.pdpdt.2022.103122
  268. Mihai Ranete, Mugur C. Grasu, Radu Dumitru, Gina Rusu, Mihai Toma, Ioana G. Lupescu. Overview of intrahepatic cholangiocarcinoma – from imaging aspects to interventional approach. Oncolog-Hematolog.ro 2019;4:16
    https://doi.org/10.26416/OnHe.49.4.2019.2738
  269. Yan Song, Shuo Lian, Huikang Fan, Changlin Ma, Lijie Zheng, Fan Huang, Shaohui Huang, Yongchang Tang, Anda Shi, Lizhuang Shu, Liming Zhao, Yunfei Xu, Sen Guo, Zengli Liu, Zongli Zhang. Bmi1 facilitates the progression of cholangiocarcinoma by inhibiting Foxn2 expression dependent on a histone H2A ubiquitination manner. Cancer Letters 2024;592:216921
    https://doi.org/10.1016/j.canlet.2024.216921
  270. Teerapich Kasemsuk, Natthiya Saehlim, Patcharee Arsakhant, Gunya Sittithumcharee, Seiji Okada, Rungnapha Saeeng. A novel synthetic acanthoic acid analogues and their cytotoxic activity in cholangiocarcinoma cells. Bioorganic & Medicinal Chemistry 2021;29:115886
    https://doi.org/10.1016/j.bmc.2020.115886
  271. Aleksey V. Kozlov, Pavel G. Tarazov, Aleksey A. Polikarpov, Andrey V. Moiseenko, Anastasia S. Turlak. Intra-arterial chemotherapy in the treatment of inoperable patients with Klatskin tumor: preliminary results. Journal of Clinical Practice 2022;13:25
    https://doi.org/10.17816/clinpract109310
  272. Maurizio Capuozzo, Mariachiara Santorsola, Loris Landi, Vincenza Granata, Francesco Perri, Venere Celotto, Oreste Gualillo, Guglielmo Nasti, Alessandro Ottaiano. Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology. IJMS 2022;23:15124
    https://doi.org/10.3390/ijms232315124
  273. Van Nghiem, Sarah Wood, Rekha Ramachandran, Grant Williams, Darryl Outlaw, Ravikumar Paluri, Young-il Kim, Olumide Gbolahan. Short- and Long-Term Survival of Metastatic Biliary Tract Cancer in the United States From 2000 to 2018. Cancer Control 2023;30
    https://doi.org/10.1177/10732748231211764
  274. Toru Shirakawa, Yoshito Tomimaru, Shiro Hayashi, Kozo Noguchi, Tsutomu Nishida, Keizo Dono. Clinical Utility of Bile Duct Axis Deviation for Differential Diagnosis Between Pancreatic Head Cancer and Bile Duct Cancer. The American Surgeon 2021;87:664
    https://doi.org/10.1177/0003134820954851
  275. David M. de Jong, Jeska A. Fritzsche, Amber S. Audhoe, Suzanne S. L. Yi, Marco J. Bruno, Rogier P. Voermans, Lydi M. J. W. van Driel. Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma—A Systematic Review and Meta-Analysis. Cancers 2022;14:2079
    https://doi.org/10.3390/cancers14092079
  276. Xiaojie Zhang, Yang Zhang, Yunming Zhang, Peng Lv, Pengfei Zhang, Chengchao Chu, Jingsong Mao, Xiaoyong Wang, Wengang Li, Gang Liu. Bio-engineered cell membrane nanovesicles as precision theranostics for perihilar cholangiocarcinoma. Biomater. Sci. 2020;8:1575
    https://doi.org/10.1039/C9BM02088H
  277. Tian Zhou, Li Liu, Hai‐Su Dai, Cheng‐Cheng Zhang, Yu He, Lei‐Da Zhang, Da‐Jiang Li, Ping Bie, Jun Ding, Zhi‐Yu Chen. Impact of body mass index on postoperative outcomes in patients undergoing radical resection for hilar cholangiocarcinoma. Journal of Surgical Oncology 2020;122:1418
    https://doi.org/10.1002/jso.26172
  278. Hwe Hoon Chung, Seung Hee Seo, Hyemin Kim, Yuil Kim, Dong Wuk Kim, Kwang Hyuck Lee, Kyu Taek Lee, Jin Seok Heo, In Woong Han, Seon Mee Park, Kee-Taek Jang, Jong Kyun Lee, Joo Kyung Park. Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays. Gut and Liver 2023;17:159
    https://doi.org/10.5009/gnl220044
  279. Zeliha Özkaraca, Sinem Toplar, Zeynep Günes. Nab-Paclitaxel, Gemcitabine Tedavisi Alan Kolanjiyokarsinoma Kanseri Olan Hastanın Fonksiyonel Sağlık Örüntülerine Göre Hemşirelik Bakımı: Olgu Sunumu. 2024;7:266
    https://doi.org/10.38108/ouhcd.1249268
  280. Massimiliano Cadamuro, Simone Brivio, Tommaso Stecca, Eleanna Kaffe, Valeria Mariotti, Chiara Milani, Romina Fiorotto, Carlo Spirli, Mario Strazzabosco, Luca Fabris. Animal models of cholangiocarcinoma: What they teach us about the human disease. Clinics and Research in Hepatology and Gastroenterology 2018;42:403
    https://doi.org/10.1016/j.clinre.2018.04.008
  281. Alexandra Zaborowski, Helen M. Heneghan, Barbara Fiore, Anthony Stafford, Tom Gallagher, Justin Geoghegan, Donal Maguire, Emir Hoti. Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol. 2020;104:2097
    https://doi.org/10.1097/TP.0000000000003114
  282. Felix Dondorf, Oliver Rohland, Aladdin Ali Deeb, Michael Ardelt, Utz Settmacher, Falk Rauchfuss. Value of palliative surgery in perihilar cholangiocarcinoma. Langenbecks Arch Surg 2023;408
    https://doi.org/10.1007/s00423-023-02854-z
  283. Valeria Simone, Oronzo Brunetti, Luigi Lupo, Mario Testini, Eugenio Maiorano, Michele Simone, Vito Longo, Christian Rolfo, Marc Peeters, Aldo Scarpa, Amalia Azzariti, Antonio Russo, Domenico Ribatti, Nicola Silvestris. Targeting Angiogenesis in Biliary Tract Cancers: An Open Option. IJMS 2017;18:418
    https://doi.org/10.3390/ijms18020418
  284. Gaya Spolverato, Dajana Glavas, D. Brock Hewitt, Zachary J Brown, Giulia Capelli, Francesca Bergamo, Mario Domenico Rizzato, Timothy M. Pawlik. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs. Expert Opinion on Pharmacotherapy 2022;23:473
    https://doi.org/10.1080/14656566.2021.2020250
  285. Estanislao Peixoto, Sujeong Jin, Kristen Thelen, Aalekhya Biswas, Seth Richard, Manuela Morleo, Adrian Mansini, Stephanie Holtorf, Fabrizia Carbone, Nunzia Pastore, Andrea Ballabio, Brunella Franco, Sergio A. Gradilone. HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020;318:G1022
    https://doi.org/10.1152/ajpgi.00033.2020
  286. Thomas Malikowski, Michael J. Levy, Ferga C. Gleeson, Andrew C. Storm, Eric J. Vargas, Mark D. Topazian, Barham K. Abu Dayyeh, Prasad G. Iyer, Elizabeth Rajan, Gregory J. Gores, Lewis R. Roberts, Vinay Chandrasekhara. Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With Cholangiocarcinoma. Hepatology 2020;72:940
    https://doi.org/10.1002/hep.31077
  287. Derong Xu, Lili Wei, Liping Zeng, Robert Mukiibi, Hongbo Xin, Feng Zhang. An integrated mRNA–lncRNA signature for overall survival prediction in cholangiocarcinoma. 2023;102:e35348
    https://doi.org/10.1097/MD.0000000000035348
  288. Changjiang Lei, Xiulan Peng, Xiaojun Gong, Ying Fan, Shenglin Wu, Ning Liu, Lei Li, Jianbin Huang, Gang Zheng, Zhixiong Long. Prognostic role of programmed death-ligand 1 expression in patients with biliary tract cancer: a meta-analysis. Aging 2019;11:12568
    https://doi.org/10.18632/aging.102588
  289. Chen Qiu, Yu-Kai Xiang, Xuan-Bo Da, Hong-Lei Zhang, Xiang-Yu Kong, Nian-Zong Hou, Cheng Zhang, Fu-Zhou Tian, Yu-Long Yang. Phospholipase A2 enzymes PLA2G2A and PLA2G12B as potential diagnostic and prognostic biomarkers in cholangiocarcinoma. World J Gastrointest Surg 2024;16:289
    https://doi.org/10.4240/wjgs.v16.i2.289
  290. Xuling Li, Ying Zhang, Yongyang Zhang. 18F-FDG PET/CT may be a suitable method for preoperative diagnosis and evaluation of Chinese older patients with hilar cholangiocarcinoma. BMC Geriatr 2018;18
    https://doi.org/10.1186/s12877-018-0846-8
  291. Worawat Songjang, Chatchai Nensat, Sutatip Pongcharoen, Arunya Jiraviriyakul. The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review). Biomed Rep 2021;15
    https://doi.org/10.3892/br.2021.1462
  292. Kim Saverno, Kristin M Zimmerman Savill, Cherrishe Brown-Bickerstaff, Angele Kotomale, Michael Rodriguez, Bruce Feinberg, Haobo Ren, Mike Blecker, Richard Kim. Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US. 2024
    https://doi.org/10.1093/oncolo/oyae204
  293. Qiang Sun, Xueyi Gong, Jianlong Wu, Zhipeng Hu, Qiao Zhang, Jingling Gong, Xiaofeng Zhu, Junyan Liu. Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma. BioMed Research International 2021;2021:1
    https://doi.org/10.1155/2021/8893652
  294. Melisa B. Nicoud, Karina Formoso, Vanina A. Medina. Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications. Front. Pharmacol. 2019;10
    https://doi.org/10.3389/fphar.2019.00556
  295. Jianfei Tu, Fazong Wu, Li Chen, Liyun Zheng, Yang Yang, Xihui Ying, Jingjing Song, Chunmiao Chen, Xianghua Hu, Zhongwei Zhao, Jiansong Ji. Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway. Front. Oncol. 2021;10
    https://doi.org/10.3389/fonc.2020.605877
  296. Jung Min Lee, Hongbeom Kim, Hee Ju Sohn, Yoo Jin Choi, Jae Seung Kang, Youngmin Han, Wooil Kwon, Jin-Young Jang. Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma versus distal bile duct cancer. Ann Surg Treat Res 2022;102:100
    https://doi.org/10.4174/astr.2022.102.2.100
  297. Jin Lee, Eun Mi Hong, Jung Han Kim, Jung Hee Kim, Jang Han Jung, Se Woo Park, Dong Hee Koh, Hyun Joo Jang. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition. Mol Biol Rep 2021;48:6231
    https://doi.org/10.1007/s11033-021-06331-y
  298. A. V. Kozlov, P. G. Tarazov, A. A. Polikarpov, A. V. Moiseenko, A. I. Urbansky, M. V. Yutkin, G. M. Yakshieva, D. A. Granov. Antegrade Endobiliary Forceps Biopsy Improves Diagnosis of Klatskin Tumor Compared to Brush Biopsy. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2022;32:45
    https://doi.org/10.22416/1382-4376-2022-32-2-45-54
  299. I.-A. Mavroeidi, J. Burghofer, S. Kalbourtzis, H. Taghizadeh, G. Webersinke, G. Piringer, S. Kasper, G. Schreil, S.T. Liffers, A. Reichinger, P. Kirchweger, S. Heibl, R. Hamacher, C.A. Schmitt, M. Schuler, G.W. Prager, D. Kersting, J. Treckmann, H.-U. Schildhaus, H. Rumpold, J.T. Siveke, B. Doleschal. Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity. ESMO Open 2024;9:103630
    https://doi.org/10.1016/j.esmoop.2024.103630
  300. Suyanee Thongchot, Alessandra Ferraresi, Chiara Vidoni, Amreen Salwa, Letizia Vallino, Yingpinyapat Kittirat, Watcharin Loilome, Nisana Namwat, Ciro Isidoro. Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis. Cancer Letters 2024;582:216589
    https://doi.org/10.1016/j.canlet.2023.216589
  301. Francesca Saffioti, Davide Roccarina, Mette Vesterhus, Johannes R. Hov, William Rosenberg, Massimo Pinzani, Stephen P. Pereira, Kirsten M. Boberg, Douglas Thorburn. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis. Eur J Clin Investigation 2019;49
    https://doi.org/10.1111/eci.13088
  302. Xiaolan Yin, Zongtao Chai, Xiaoting Sun, Jin Chen, Xiufang Wu, Liying Yang, Xiaobao Zhou, Feng Liu. Overexpression of microRNA‑96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via MTSS1. Exp Ther Med 2020
    https://doi.org/10.3892/etm.2020.8502
  303. Nagappan Kumar, Arvind Kumar, Dipanjali Mondal. Focal Intrahepatic Duct Dilatation (FIDD): a Finding That Mandates Further Evaluation That May Amount to Liver Resection. Indian J Surg 2023
    https://doi.org/10.1007/s12262-023-03999-3
  304. David Irwin. Update on Cholangiocarcinoma. Digestive Disease Interventions 2022;06:209
    https://doi.org/10.1055/s-0042-1751238
  305. Sarunya Kitdumrongthum, Chanatip Metheetrairut, Varodom Charoensawan, Puey Ounjai, Keatdamrong Janpipatkul, Wittaya Panvongsa, Jittima Weerachayaphorn, Pawinee Piyachaturawat, Arthit Chairoungdua. Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes. Life Sciences 2018;210:65
    https://doi.org/10.1016/j.lfs.2018.08.058
  306. Lin Xu, Peng Wang, Wei Zhang, Weiran Li, Tao Liu, Xu Che. Dual-Specificity Phosphatase 11 Is a Prognostic Biomarker of Intrahepatic Cholangiocarcinoma. Front. Oncol. 2021;11
    https://doi.org/10.3389/fonc.2021.757498
  307. Jun Wu, Jiyao Sheng, Hanjiao Qin, Mengying Cui, Yongsheng Yang, Xuewen Zhang. The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries. Front. Oncol. 2021;11
    https://doi.org/10.3389/fonc.2021.628636
  308. Shaoyi Chen, Zuxiao Chen, Zongyan Li, Shiying Li, Zilong Wen, Liangqi Cao, Yubin Chen, Ping Xue, Haiyan Li, Dawei Zhang. Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256. Cell Death Dis 2022;13
    https://doi.org/10.1038/s41419-022-04534-0
  309. Konstantinos Laschos, Dimitra Ioanna Lampropoulou, Gerasimos Aravantinos, Maria Piperis, Dimitrios Filippou, George Theodoropoulos, Maria Gazouli. Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope?. WJGS 2020;12:407
    https://doi.org/10.4240/wjgs.v12.i10.407
  310. D. Brock Hewitt, Zachary J. Brown, Timothy M Pawlik. Surgical management of intrahepatic cholangiocarcinoma. Expert Review of Anticancer Therapy 2022;22:27
    https://doi.org/10.1080/14737140.2022.1999809
  311. Ye-Yu Zhao, Si-Hai Chen, Qin-Si Wan. A prognostic nomogram for distal bile duct cancer from Surveillance, Epidemiology, and End Results (SEER) database based on the STROBE compliant. 2019;98:e17903
    https://doi.org/10.1097/MD.0000000000017903
  312. Junjie Kong, Shu Shen, Zifei Zhang, Wentao Wang. Identification of hub genes and pathways in cholangiocarcinoma by coexpression analysis. CBM 2020;27:505
    https://doi.org/10.3233/CBM-190038
  313. Said Abu-Alkhair Mohamed. Immunohistochemical study of hepatocyte paraffin 1 antibody, monoclonal antibody 31, and cytokeratin 7 in primary and secondary liver carcinomas. 2021;19:80
    https://doi.org/10.4103/AZMJ.AZMJ_88_19
  314. Botao Duan, Xuekai Zhao, Songsong Fan, Lei Zhou, Xingyuan Zhang. A rare case report of obstructive jaundice caused by mucus-producing cholangiocarcinoma. 2022;101:e28478
    https://doi.org/10.1097/MD.0000000000028478
  315. Seon Mee Park, So Young Kim, Kyoung Eun Yeob, Dong Wook Shin, Joung-Ho Han, Jong Heon Park, Jong Hyock Park. Disparities in the Diagnosis and Treatment of Bile Duct Cancer in People with Disabilities: A National Cohort Study in South Korea. IJERPH 2022;19:16625
    https://doi.org/10.3390/ijerph192416625
  316. Weiqian Chen, Jingjing Song, Siyu Liu, Bufu Tang, Lin Shen, Jinyu Zhu, Shiji Fang, Fazong Wu, Liyun Zheng, Rongfang Qiu, Chunmiao Chen, Yang Gao, Jianfei Tu, Zhongwei Zhao, Jiansong Ji. USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3. J Biomed Sci 2021;28
    https://doi.org/10.1186/s12929-021-00738-2
  317. Andrea Palloni, Silvia Bisello, Ilaria Maggio, Maria Massucci, Andrea Galuppi, Alessandro Di Federico, Alessandro Rizzo, Angela Dalia Ricci, Giambattista Siepe, Alessio Giuseppe Morganti, Giovanni Brandi, Giorgio Frega. The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma. Current Oncology 2023;30:4754
    https://doi.org/10.3390/curroncol30050358
  318. Osmay Cardoso. Radiopaedia.org. 2023.
    https://doi.org/10.53347/rID-170742
  319. Shaobo Yu, Xin Gao, Sidi Liu, Xiangjun Sha, Siyuan Zhang, Xinmiao Zhang, Dongsheng Sun, Xingming Jiang. LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling. Cancer Gene Ther 2024;31:552
    https://doi.org/10.1038/s41417-024-00726-2
  320. Marcella Steffani, Ulrich Nitsche, Johanna Ollesky, Benedikt Kaufmann, Sarah Schulze, Alexander Novotny, Helmut Friess, Norbert Hüser, Christian Stoess, Daniel Hartmann. Liver Fibrosis Is Associated with Poorer Overall Survival and Higher Recurrence Rate in Patients with Cholangiocarcinoma. Dig Surg 2024;41:53
    https://doi.org/10.1159/000535733
  321. Junnan Liang, Tongtong Liu, Jingyu Liao, Lu Zhang, Mi Zhou, Weiqi Xu, Yi He, Guangzhen Cai, Guannan Jin, Jia Song, Ganxun Li, Huifang Liang, Zeyang Ding, Bixiang Zhang. Development and validation of a CpG island methylator phenotype‐related prognostic signature for cholangiocarcinoma. Journal Cellular Physiology 2021;236:3143
    https://doi.org/10.1002/jcp.30082
  322. Marco Filauro, Giulio Angelini, Federico Fazio, Andrea Barberis. Surgical Management of Elderly Patients. 2021.
    https://doi.org/10.1007/978-3-319-60861-7_21
  323. Meng-Shin Shiao, Khajeelak Chiablaem, Varodom Charoensawan, Nuttapong Ngamphaiboon, Natini Jinawath. Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type. Front. Genet. 2018;9
    https://doi.org/10.3389/fgene.2018.00309
  324. Zachary J Brown, Samantha M. Ruff, Timothy M Pawlik. Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapy. Expert Review of Anticancer Therapy 2023;23:257
    https://doi.org/10.1080/14737140.2023.2176846
  325. Gregory Greco, Paul Jennings, Alexis Coleman, Syed Hussain Abbas. Cutaneous Cholangiocarcinoma: An Interesting Presentation. 2020;8:e2980
    https://doi.org/10.1097/GOX.0000000000002980
  326. Tianli Chen, Kangshuai Li, Zengli Liu, Jialiang Liu, Yue Wang, Rongqi Sun, Zhipeng Li, Bo Qiu, Xiaoming Zhang, Guangli Ren, Yunfei Xu, Zongli Zhang. WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways. Molecular Therapy 2021;29:2134
    https://doi.org/10.1016/j.ymthe.2021.02.017
  327. Obaid Rehman, Bradley Sackfield, Viveksandeep Thoguluva Chandrasekar, Jorge Oliver, Ganesh Aswath. A Case Report of CHEK2 and MUTYH Germline Mutations Associated With Cholangiocarcinoma in a Young Patient. 2022
    https://doi.org/10.7759/cureus.22631
  328. Rittibet Yapasert, Ratana Banjerdpongchai, Jelena Zivkovic. Gambogic Acid and Piperine Synergistically Induce Apoptosis in Human Cholangiocarcinoma Cell via Caspase and Mitochondria-Mediated Pathway. Evidence-Based Complementary and Alternative Medicine 2022;2022:1
    https://doi.org/10.1155/2022/6288742
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd